Document:

Form of Warrant

 Exhibit 4.1 

THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES
LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OR (B) AN AVAILABLE EXEMPTION FROM, OR IN A
TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS
TRANSFER AGENT OR (II) UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT (PROVIDED THAT THE TRANSFEROR PROVIDES THE COMPANY WITH REASONABLE ASSURANCES (IN THE FORM OF SELLER AND BROKER REPRESENTATION LETTERS) THAT THE SECURITIES MAY BE SOLD PURSUANT
TO SUCH RULE). NO REPRESENTATION IS MADE BY THE ISSUER AS TO THE AVAILABILITY OF THE EXEMPTION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT FOR RESALES OF THESE SECURITIES. 

WARRANT 

to purchase 

[                ] 

Non-Voting Common Shares 

of PORTER BANCORP, INC. 

Issue Date: June 30, 2010 

1. Definitions. Unless the context otherwise requires, when used herein the following terms shall have the meanings indicated.

 “Affiliate” has the meaning ascribed to it in the Purchase Agreement. 

“Board of Directors” means the board of directors of the Company, including any duly authorized committee thereof.

 “Business Combination” means a merger, consolidation, statutory share exchange or similar transaction that
requires the approval of the Company’s stockholders. 
 “Business Day” means any day except Saturday,
Sunday and any day on which banking institutions in the State of New York generally are authorized or required by law or other governmental actions to close. 

“Capital Stock” means (A) with respect to any Person that is a corporation or company, any and all shares,
interests, participations or other equivalents (however designated) of capital or capital stock of such Person and (B) with respect to any Person that is not a corporation or company, any and all partnership or other equity interests of such
Person. 

 “Charter” means, with respect to any Person, its certificate or articles of
incorporation, articles of association, or similar organizational document. 
 “Common Stock” means,
collectively the Non-Voting Common Stock and Voting Common Stock, and each of them as the context may require. 

“Company” means Porter Bancorp, Inc. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and
regulations promulgated thereunder. 
 “Exercise Price” means $11.50 per Share. 

“Expiration Time” has the meaning set forth in Section 3. 

“Fair Market Value” means, with respect to any security or other property, the fair market value of such security or
other property as determined by the Board of Directors, acting in good faith. 
 “Issue Date” means the first
date set forth above. 
 “Market Price” means, with respect to a particular security, on
any given day, the last reported sale price regular way or, in case no such reported sale takes place on such day, the average of the last closing bid and ask prices regular way, in either case on the principal national securities exchange on which
the applicable securities are listed or admitted to trading, or if not listed or admitted to trading on any national securities exchange, the average of the closing bid and ask prices as furnished by two members of the Financial Industry Regulatory
Authority, Inc. selected from time to time by the Company for that purpose. “Market Price” shall be determined without reference to after hours or extended hours trading. For the purposes of determining the Market Price on the
“Trading Day” preceding, on or following the occurrence of an event, (i) that Trading Day shall be deemed to commence immediately after the regular scheduled closing time of trading on the New York Stock Exchange or, if trading is
closed at an earlier time, such earlier time and (ii) that Trading Day shall end at the next regular scheduled closing time, or if trading is closed at an earlier time, such earlier time (for the avoidance of doubt, and as an example, if the
Market Price is to be determined as of the last Trading Day preceding a specified event and the closing time of trading on a particular day is 4:00 p.m. and the specified event occurs at 5:00 p.m. on that day, the Market Price would be determined by
reference to such 4:00 p.m. closing price).  
 “Non-Voting Common Stock” means the non-voting common
shares of the Company, no par value. 
 “Ordinary Cash Dividends” means a regular cash dividend on shares of
Common Stock out of surplus or net profits legally available therefor (determined in accordance with generally accepted accounting principles in effect from time to time). 
  

 2 

 “Person” has the meaning ascribed to it in the Purchase Agreement.

 “Pro Rata Repurchase” means any purchase of shares of Common Stock by the Company or any Affiliate thereof
pursuant to (A) any tender offer or exchange offer subject to Section 13(e) or 14(e) of the Exchange Act or Regulation 14E promulgated thereunder or (B) any other offer available to substantially all holders of Common Stock, in the
case of both (A) or (B), whether for cash, shares of Capital Stock of the Company, other securities of the Company, evidences of indebtedness of the Company or any other Person or any other property (including, without limitation, shares of
Capital Stock, other securities or evidences of indebtedness of a subsidiary), or any combination thereof, effected while this Warrant is outstanding. The “Effective Date” of a Pro Rata Repurchase shall mean the date of acceptance
of shares for purchase or exchange by the Company under any tender or exchange offer which is a Pro Rata Repurchase or the date of purchase with respect to any Pro Rata Repurchase that is not a tender or exchange offer. 

“Purchase Agreement” means the Securities Purchase Agreement dated as of June 30, 2010, as amended from time to
time, between the Company and the Purchasers named therein, including all annexes and schedules thereto. 

“Registration Rights Agreement” means the Registration Rights Agreement dated as of June 30, 2010, as amended from
time to time, between the Company and the Holders named therein, including all annexes and schedules thereto. 

“SEC” means the U.S. Securities and Exchange Commission. 

“Securities Act” means the Securities Act of 1933, as amended, or any successor statute, and the rules and regulations
promulgated thereunder. 
 “Shareholder Approval Date” means the date on which the Company’s shareholders
approve a proposal authorizing a new class of Non-Voting Common Stock to allow for the exercise of the Warrants. 

“Shares” has the meaning set forth in Section 2. 

“Trading Day” means (A) if the shares of Voting Common Stock are not traded on any national or regional securities
exchange or association or over-the-counter market, a Business Day or (B) if the shares of Voting Common Stock are traded on any national or regional securities exchange or association or over-the-counter market, a Business Day on which such
relevant exchange or quotation system is scheduled to be open for business and on which the shares of Voting Common Stock are not suspended from trading on any national or regional securities exchange or association or over-the-counter market for
any period or periods aggregating one half hour or longer. 
 “U.S. GAAP” means United States generally
accepted accounting principles. 
  

 3 

 “Voting Common Stock” means the common shares of the Company, no par value,
which have the right to vote pursuant to the Company’s Charter. 
 “Warrantholder” has the meaning set
forth in Section 2. 
 “Warrant” means this Warrant, issued pursuant to the Purchase Agreement.

 2. Number of Shares; Exercise Price. This certifies that, for value received,
[                                    ] or its permitted
assigns (the “Warrantholder”) is entitled, upon the terms and subject to the conditions hereinafter set forth, to acquire from the Company, in whole or in part, up to
[            ] fully paid and nonassessable shares of Non-Voting Common Stock at a purchase price per share of Non-Voting Common Stock equal to the Exercise Price. The number of
shares of Non-Voting Common Stock (the “Shares”) and the Exercise Price are subject to adjustment as provided herein, and all references to “Non-Voting Common Stock,” “Shares” and “Exercise Price”
herein shall be deemed to include any such adjustment or series of adjustments. 
 3. Exercise of Warrant; Term. Subject
to Section 2, to the extent permitted by applicable laws and regulations, the right to purchase the Shares represented by this Warrant is exercisable, in whole or in part by the Warrantholder, at any time or from time to time after the
Shareholder Approval Date, but in no event later than 5:00 p.m., Louisville, Kentucky time on the fifth anniversary of the Shareholder Approval Date (the “Expiration Time”), by (A) the surrender of this Warrant and Notice of
Exercise annexed hereto, duly completed and executed on behalf of the Warrantholder, at the principal executive office of the Company located at 2500 Eastpoint Parkway, Louisville, KY 40223 (or such other office or agency of the Company in the
United States as it may designate by notice in writing to the Warrantholder at the address of the Warrantholder appearing on the books of the Company), and (B) payment of the Exercise Price for the Shares thereby purchased, with the consent of
both the Company and the Warrantholder, by tendering in cash, by certified or cashier’s check payable to the order of the Company, or by wire transfer of immediately available funds to an account designated by the Company. 

If the Warrantholder does not exercise this Warrant in its entirety, the Warrantholder will be entitled to receive from the Company
within a reasonable time, and in any event not exceeding three Business Days, a new warrant in substantially identical form for the purchase of that number of Shares equal to the difference between the number of Shares subject to this Warrant and
the number of Shares as to which this Warrant is so exercised. 
 4. Issuance of Shares; Authorization; Listing.
Certificates for Shares issued upon exercise of this Warrant will be issued in such name or names as the Warrantholder may designate and will be delivered to such named Person or Persons within a reasonable time, not to exceed three Business Days
after the date on which this Warrant has been duly exercised in accordance with the terms of this Warrant. The Company hereby represents and warrants that any Shares issued upon the exercise of this Warrant in accordance with the provisions of
Section 3 will be duly and validly authorized and issued, fully paid and nonassessable and free from all taxes, liens and charges (other than liens or charges created by the Warrantholder, income and franchise taxes incurred in connection with
the exercise of the Warrant or taxes in respect of any transfer occurring contemporaneously therewith). The Company agrees that the Shares so issued 

 

 4 

 
will be deemed to have been issued to the Warrantholder as of the close of business on the date on which this Warrant and payment of the Exercise Price are delivered to the Company in accordance
with the terms of this Warrant, notwithstanding that the stock transfer books of the Company may then be closed or certificates representing such Shares may not be actually delivered on such date. The Company will at all times reserve and keep
available, out of its authorized but unissued Non-Voting Common Stock, solely for the purpose of providing for the exercise of this Warrant, the aggregate number of shares of Non-Voting Common Stock then issuable upon exercise of this Warrant at any
time. The Company will (A) procure, at its sole expense, the listing of the Voting Common Stock issuable upon conversion of the Non-Voting Common Stock issuable upon exercise of this Warrant at any time, subject to issuance or notice of
issuance, on all principal stock exchanges on which the Voting Common Stock is then listed or traded and (B) maintain such listings of such Voting Common Stock at all times after issuance. The Company will use reasonable best efforts to ensure
that the Shares may be issued without violation of any applicable law or regulation or of any requirement of any securities exchange on which the Shares are listed or traded. 

5. No Fractional Shares or Scrip. No fractional Shares or scrip representing fractional Shares shall be issued upon any exercise
of this Warrant. In lieu of any fractional Share to which the Warrantholder would otherwise be entitled, the Warrantholder shall be entitled to receive a cash payment equal to the Market Price of the Voting Common Stock on the last Trading Day
preceding the date of exercise less the pro-rated Exercise Price for such fractional share. 
 6. No Rights as Stockholders;
Transfer Books. This Warrant does not entitle the Warrantholder to any voting rights or other rights as a stockholder of the Company prior to the date of exercise hereof. The Company will at no time close its transfer books against transfer of
this Warrant in any manner which interferes with the timely exercise of this Warrant. 
 7. Charges, Taxes and Expenses.
Issuance of certificates for Shares to the Warrantholder upon the exercise of this Warrant shall be made without charge to the Warrantholder for any issue or transfer tax or other incidental expense in respect of the issuance of such certificates,
all of which taxes and expenses shall be paid by the Company. 
 8. Transfer/Assignment. 

(A) Subject to compliance with clause (B) of this Section 8, this Warrant and all rights hereunder are transferable, in whole
or in part, upon the books of the Company by the registered holder hereof in person or by duly authorized attorney, and a new warrant shall be made and delivered by the Company, of the same tenor and date as this Warrant but registered in the name
of one or more transferees, upon surrender of this Warrant, duly endorsed, to the office or agency of the Company described in Section 3. All expenses (other than stock transfer taxes) and other charges payable in connection with the
preparation, execution and delivery of the new warrants pursuant to this Section 8 shall be paid by the Company. 
 (B) The
transfer of the Warrant and the Shares issued upon exercise of the Warrant are subject to the restrictions set forth in Section 4.1 of the Purchase Agreement. If and for so long as required by the Purchase Agreement, this Warrant shall contain
the legend as set forth in Section 4.1(b) of the Purchase Agreement. 
  

 5 

 9. Exchange and Registry of Warrant. This Warrant is exchangeable, upon the surrender
hereof by the Warrantholder to the Company, for a new warrant or warrants of like tenor and representing the right to purchase the same aggregate number of Shares. The Company shall maintain a registry showing the name and address of the
Warrantholder as the registered holder of this Warrant. This Warrant may be surrendered for exchange or exercise in accordance with its terms, at the office of the Company, and the Company shall be entitled to rely in all respects, prior to written
notice to the contrary, upon such registry. 
 10. Loss, Theft, Destruction or Mutilation of Warrant. Upon receipt by the
Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant, and in the case of any such loss, theft or destruction, upon receipt of a bond, indemnity or security reasonably satisfactory to the
Company, or, in the case of any such mutilation, upon surrender and cancellation of this Warrant, the Company shall make and deliver, in lieu of such lost, stolen, destroyed or mutilated Warrant, a new Warrant of like tenor and representing the
right to purchase the same aggregate number of Shares as provided for in such lost, stolen, destroyed or mutilated Warrant. 

11. Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding day that is a Business Day. 

12. Registration. 

(A) Registration Rights. The Company acknowledges that this Warrant and the Non-Voting Common Shares issuable upon exercise of
this Warrant are Additional Registrable Securities (as such term is defined in the Registration Rights Agreement) and the Company covenants to observe and perform each of its obligations under the Registration Rights Agreement with respect to this
Warrant, the Non-Voting Common Stock issuable upon exercise of this Warrant and the Voting Common Stock issuable upon conversion of such Non-Voting Common Stock. 

(B) Rule 144 Information. The Company covenants that it will use its reasonable best efforts to timely file all reports and other
documents required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations promulgated by the SEC thereunder (or, if the Company is not required to file such reports, it will, upon the request of any
Warrantholder, make publicly available such information as necessary to permit sales pursuant to Rule 144 under the Securities Act), and it will use reasonable best efforts to take such further action as any Warrantholder may reasonably request, in
each case to the extent required from time to time to enable such holder to, if permitted by the terms of this Warrant and the Purchase Agreement, sell this Warrant without registration under the Securities Act within the limitation of the
exemptions provided by (A) Rule 144 under the Securities Act, as such rule may be amended from time to time, or (B) any successor rule or regulation hereafter adopted by the SEC. Upon the written request of any Warrantholder, the Company
will deliver to such Warrantholder a written statement that it has complied with such requirements. 
  

 6 

 13. Adjustments and Other Rights. The Exercise Price and the number of Shares
issuable upon exercise of this Warrant shall be subject to adjustment from time to time as follows; provided, that if more than one subsection of this Section 13 is applicable to a single event, the subsection shall be applied that
produces the largest adjustment and no single event shall cause an adjustment under more than one subsection of this Section 13 so as to result in duplication: 

(A) Stock Splits, Subdivisions, Reclassifications or Combinations. If the Company shall (i) declare and pay a dividend or
make a distribution on its Common Stock in shares of Common Stock, (ii) subdivide or reclassify the outstanding shares of Common Stock into a greater number of shares, or (iii) combine or reclassify the outstanding shares of Common Stock
into a smaller number of shares, the number of Shares issuable upon exercise of this Warrant at the time of the record date for such dividend or distribution or the effective date of such subdivision, combination or reclassification shall be
proportionately adjusted so that the Warrantholder after such date shall be entitled to purchase the number of shares of Non-Voting Common Stock which such holder would have owned or been entitled to receive in respect of the shares of Non-Voting
Common Stock subject to this Warrant after such date had this Warrant been exercised immediately prior to such date. In such event, the Exercise Price in effect at the time of the record date for such dividend or distribution or the effective date
of such subdivision, combination or reclassification shall be adjusted to the number obtained by dividing (x) the product of (1) the number of Shares issuable upon the exercise of this Warrant before such adjustment and (2) the
Exercise Price in effect immediately prior to the record or effective date, as the case may be, for the dividend, distribution, subdivision, combination or reclassification giving rise to this adjustment by (y) the new number of Shares issuable
upon exercise of the Warrant determined pursuant to the immediately preceding sentence. 
 (B) Business Combinations. In
case of any Business Combination or reclassification of Common Stock (other than a reclassification of Common Stock referred to in Section 13(A)), the Warrantholder’s right to receive Shares upon exercise of this Warrant shall be converted
into the right to exercise this Warrant to acquire the number of shares of stock or other securities or property (including cash) which the Non-Voting Common Stock issuable (at the time of such Business Combination or reclassification) upon exercise
of this Warrant immediately prior to such Business Combination or reclassification would have been entitled to receive upon consummation of such Business Combination or reclassification; and in any such case, if necessary, the provisions set forth
herein with respect to the rights and interests thereafter of the Warrantholder shall be appropriately adjusted so as to be applicable, as nearly as may reasonably be, to the Warrantholder’s right to exercise this Warrant in exchange for any
shares of stock or other securities or property pursuant to this paragraph. In determining the kind and amount of stock, securities or the property receivable upon exercise of this Warrant following the consummation of such Business Combination, if
the holders of Common Stock have the right to elect the kind or amount of consideration receivable upon consummation of such Business Combination, then the consideration that the Warrantholder shall be entitled to receive upon exercise shall be
deemed to be the types and amounts of consideration received by the majority of all holders of the shares of Common Stock that affirmatively make an election (or of all such holders if none make an election). 

 

 7 

 (C) Other Distributions. In case the Company shall fix a record date for the making
of a distribution to all holders of shares of its Common Stock of securities, evidences of indebtedness, assets, cash, rights or warrants (excluding Ordinary Cash Dividends, dividends of its Common Stock and other dividends or distributions referred
to in Section 13(A)), in each such case, the Exercise Price in effect prior to such record date shall be reduced immediately thereafter to the price determined by multiplying the Exercise Price in effect immediately prior to the reduction by
the quotient of (x) the Market Price of the Voting Common Stock on the last trading day preceding the first date on which the Voting Common Stock trades regular way on the principal national securities exchange on which the Voting Common Stock
is listed or admitted to trading without the right to receive such distribution, minus the amount of cash and/or the Fair Market Value of the securities, evidences of indebtedness, assets, rights or warrants to be so distributed in respect of one
share of Voting Common Stock (such amount and/or Fair Market Value, the “Per Share Fair Market Value”) divided by (y) such Market Price on such date specified in clause (x); such adjustment shall be made successively whenever
such a record date is fixed. In such event, the number of Shares issuable upon the exercise of this Warrant shall be increased to the number obtained by dividing (x) the product of (1) the number of Shares issuable upon the exercise of
this Warrant before such adjustment, and (2) the Exercise Price in effect immediately prior to the distribution giving rise to this adjustment by (y) the new Exercise Price determined in accordance with the immediately preceding sentence.
In the case of adjustment for a cash dividend that is, or is coincident with, a regular quarterly cash dividend, the Per Share Fair Market Value would be reduced by the per share amount of the portion of the cash dividend that would constitute an
Ordinary Cash Dividend. In the event that such distribution is not so made, the Exercise Price and the number of Shares issuable upon exercise of this Warrant then in effect shall be readjusted, effective as of the date when the Board of Directors
determines not to distribute such shares, evidences of indebtedness, assets, rights, cash or warrants, as the case may be, to the Exercise Price that would then be in effect and the number of Shares that would then be issuable upon exercise of this
Warrant if such record date had not been fixed. 
 (D) Certain Repurchases of Non-Voting Common Stock. In case the
Company effects a Pro Rata Repurchase of Common Stock, then the Exercise Price shall be reduced to the price determined by multiplying the Exercise Price in effect immediately prior to the Effective Date of such Pro Rata Repurchase by a fraction of
which the numerator shall be (i) the product of (x) the number of shares of Common Stock outstanding immediately before such Pro Rata Repurchase and (y) the Market Price of a share of Voting Common Stock on the trading day immediately
preceding the first public announcement by the Company or any of its Affiliates of the intent to effect such Pro Rata Repurchase, minus (ii) the aggregate purchase price of the Pro Rata Repurchase, and of which the denominator shall be the
product of (x) the number of shares of Common Stock outstanding immediately prior to such Pro Rata Repurchase minus the number of shares of Common Stock so repurchased and (y) the Market Price per share of Voting Common Stock on the
trading day immediately preceding the first public announcement by the Company or any of its Affiliates of the intent to effect such Pro Rata Repurchase. In such event, the number of shares of Non-Voting Common Stock issuable upon the exercise of
this Warrant shall 
  

 8 

 
be increased to the number obtained by dividing (x) the product of (1) the number of Shares issuable upon the exercise of this Warrant before such adjustment, and (2) the Exercise
Price in effect immediately prior to the Pro Rata Repurchase giving rise to this adjustment by (y) the new Exercise Price determined in accordance with the immediately preceding sentence. For the avoidance of doubt, no increase to the Exercise
Price or decrease in the number of Shares issuable upon exercise of this Warrant shall be made pursuant to this Section 13(D). 

(E) Rounding of Calculations; Minimum Adjustments. All calculations under this Section 13 shall be made to the nearest
one-tenth (1/10th) of a cent or to the nearest one-hundredth (1/100th) of a share, as the case may be. Any provision of this Section 13 to the contrary notwithstanding, no adjustment in the Exercise Price or the number of Shares into
which this Warrant is exercisable shall be made if the amount of such adjustment would be less than $0.01 or one-tenth (1/10th) of a share of Non-Voting Common Stock, but any such amount shall be carried forward and an adjustment with respect
thereto shall be made at the time of and together with any subsequent adjustment which, together with such amount and any other amount or amounts so carried forward, shall aggregate $0.01 or 1/10th of a share of Non-Voting Common Stock, or more.

 (F) Timing of Issuance of Additional Common Stock Upon Certain Adjustments. In any case in which the provisions of
this Section 13 shall require that an adjustment shall become effective immediately after a record date for an event, the Company may defer until the occurrence of such event (i) issuing to the Warrantholder of this Warrant exercised after
such record date and before the occurrence of such event the additional shares of Non-Voting Common Stock issuable upon such exercise by reason of the adjustment required by such event over and above the shares of Non-Voting Common Stock issuable
upon such exercise before giving effect to such adjustment and (ii) paying to such Warrantholder any amount of cash in lieu of a fractional share of Non-Voting Common Stock; provided, however, that the Company upon request shall deliver
to such Warrantholder a due bill or other appropriate instrument evidencing such Warrantholder’s right to receive such additional shares, and such cash, upon the occurrence of the event requiring such adjustment. 

(G) Statement Regarding Adjustments. Whenever the Exercise Price or the number of Shares into which this Warrant is exercisable
shall be adjusted as provided in this Section 13, the Company shall forthwith file at the principal office of the Company a statement showing in reasonable detail the facts requiring such adjustment and the Exercise Price that shall be in
effect and the number of Shares into which this Warrant shall be exercisable after such adjustment, and the Company shall also cause a copy of such statement to be sent by mail, first class postage prepaid, to the Warrantholder at the address
appearing in the Company’s records. 
 (H) Notice of Adjustment Event. In the event that the Company shall propose
to take any action of the type described in this Section 13 (but only if the action of the type described in this Section 13 would result in an adjustment in the Exercise Price or the number of Shares into which this Warrant is exercisable
or a change in the type of securities or property to be delivered upon exercise of this Warrant), the Company shall give notice to the Warrantholder, in the manner set forth in Section 13(G), which notice shall specify the record date, if any,
with respect to any such action and the approximate date on which such action is to take place. Such notice 
  

 9 

 
shall also set forth the facts with respect thereto as shall be reasonably necessary to indicate the effect on the Exercise Price and the number, kind or class of shares or other securities or
property which shall be deliverable upon exercise of this Warrant. In the case of any action which would require the fixing of a record date, such notice shall be given at least 10 days prior to the date so fixed, and in case of all other action,
such notice shall be given at least 15 days prior to the taking of such proposed action. Failure to give such notice, or any defect therein, shall not affect the legality or validity of any such action. 

(I) Proceedings Prior to Any Action Requiring Adjustment. As a condition precedent to the taking of any action which would require
an adjustment pursuant to this Section 13, the Company shall take any action which may be necessary, including obtaining regulatory, New York Stock Exchange, NASDAQ Stock Market or other applicable national securities exchange or stockholder
approvals or exemptions, in order that the Company may thereafter validly and legally issue as fully paid and nonassessable all Shares that the Warrantholder is entitled to receive upon exercise of this Warrant pursuant to this Section 13.

 (J) Adjustment Rules. Any adjustments pursuant to this Section 13 shall be made successively whenever an event
referred to herein shall occur. If an adjustment in Exercise Price made hereunder would reduce the Exercise Price to an amount below par value of the Non-Voting Common Stock, then such adjustment in Exercise Price made hereunder shall reduce the
Exercise Price to the par value of the Non-Voting Common Stock. 
 14. Exchange. At any time following the date on which
the shares of Voting Common Stock of the Company are no longer listed or admitted to trading on a national securities exchange (other than in connection with any Business Combination), the Warrantholder may cause the Company to exchange all or a
portion of this Warrant for an economic interest of the Company classified as permanent equity under U.S. GAAP having a value equal to the Fair Market Value of the portion of the Warrant so exchanged. 

15. No Impairment. The Company will not, by amendment of its Charter or through any reorganization, transfer of assets,
consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in
good faith assist in the carrying out of all the provisions of this Warrant and in taking of all such action as may be necessary or appropriate in order to protect the rights of the Warrantholder. 

16. Governing Law. This Warrant will be governed by and construed in accordance with the federal law of the United
States if and to the extent such law is applicable, and otherwise in accordance with the laws of the Commonwealth of Kentucky applicable to contracts made and to be performed entirely therein. Each of the Company and the Warrantholder agrees
(a) to submit to the exclusive jurisdiction and venue of the United States District Court for the Western District of Kentucky for any civil action, suit or proceeding arising out of or relating to this Warrant or the transactions contemplated
hereby, and (b) that notice may be served upon the Company at the address in Section 20 below and upon the Warrantholder at the address for the Warrantholder set forth in the registry maintained by the Company pursuant to Section 9
hereof. To the extent permitted 
  

 10 

 
by applicable law, each of the Company and the Warrantholder hereby unconditionally waives trial by jury in any civil legal action or proceeding relating to the Warrant or the transactions
contemplated hereby or thereby. 
 17. Binding Effect. This Warrant shall be binding upon any successors or assigns
of the Company. 
 18. Amendments. This Warrant may be amended and the observance of any term of this Warrant may be
waived only with the written consent of the Company and the Warrantholder. 
 19. Prohibited Actions. The Company agrees
that it will not take any action which would entitle the Warrantholder to an adjustment of the Exercise Price if the total number of shares of Non-Voting Common Stock issuable after such action upon exercise of this Warrant, together with all shares
of Non-Voting Common Stock then outstanding and all shares of Non-Voting Common Stock then issuable upon the exercise of all outstanding options, warrants, conversion and other rights, would exceed the total number of shares of Non-Voting Common
Stock then authorized by its Charter. 
 20. Notices. Any notice, request, instruction or other document to be given
hereunder by any party to the other will be in writing and will be deemed to have been duly given (a) on the date of delivery if delivered personally, or by facsimile, upon confirmation of receipt, or (b) on the second Business Day
following the date of dispatch if delivered by a recognized next day courier service. All notices hereunder shall be delivered, if to the Company, to the address listed in Section 3, and, if to the Warrantholder, to the address appearing on the
books of the Company, or pursuant to such other instructions as may be designated in writing by the party to receive such notice. 

21. Entire Agreement. This Warrant contains the entire agreement between the parties with respect to the subject matter hereof and
supersedes all prior and contemporaneous arrangements or undertakings with respect thereto. 
 [Remainder of page
intentionally left blank] 
  

 11 

 [Form of Notice of Exercise] 

Date:                     

  

	TO:	Porter Bancorp, Inc. 

  

	RE:	Election to Purchase Non-Voting Common Stock 

The undersigned, pursuant to the provisions set forth in the attached Warrant, hereby agrees to subscribe for and purchase the number of
shares of the Non-Voting Common Stock set forth below covered by such Warrant. The undersigned, in accordance with Section 3 of the Warrant, hereby agrees to pay the aggregate Exercise Price for such shares of Non-Voting Common Stock in the
manner set forth below. A new warrant evidencing the remaining shares of Non-Voting Common Stock covered by such Warrant, but not yet subscribed for and purchased, if any, should be issued in the name set forth below. 

Number of Shares of Non-Voting Common Stock
                                        

 Method of Payment of Exercise Price (note if cashless exercise pursuant to Section 3(i) of the Warrant or cash exercise pursuant to
Section 3(ii) of the Warrant, with consent of the Company and the Warrantholder)         
                                     

Aggregate Exercise Price:         
                                     

 

			
	 Holder:
	 	  

	 By:
	 	  

	 Name:
	 	  

	 Title:
	 	  

 

 12 

 IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by a duly
authorized officer. 
  

					
	 Dated: June 30, 2010
	 		 	
		
		 	 COMPANY: PORTER BANCORP, INC.

			
		 	By:	 	  

		 		 	Name: Maria L. Bouvette
		 		 	Title: President, CEO and Secretary
		
		 	 Attest:

			
		 	By:	 	  

		 		 	Name: J. Chester Porter
		 		 	Title: Chairman of the Board

 [Signature
Page to Warrant] 
  

 13Securities Purchase Agreement

 Exhibit 10.1 

SECURITIES PURCHASE AGREEMENT 

This Securities Purchase Agreement (this “Agreement”) is dated as of June 30, 2010, by and among Porter Bancorp,
Inc., a Kentucky corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the
“Purchasers”). 
 RECITALS 

A. The Company and each Purchaser is executing and delivering this Agreement in the same form as each other Purchaser, and in
reliance upon the exemption from securities registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506 of Regulation D (“Regulation D”)
as promulgated by the United States Securities and Exchange Commission (the “Commission”) under the Securities Act. 

B. Each Purchaser, severally and not jointly, wishes to purchase, and the Company wishes to sell, upon the terms and conditions
stated in this Agreement, (i) that aggregate number of common shares, no par value, set forth below such Purchaser’s name on the signature page of this Agreement (which aggregate amount for all Purchasers together shall be not less
than 1,755,747 Shares and shall be collectively referred to herein as the “Common Shares”); (ii) that aggregate number of shares of the Company’s Series B mandatorily convertible cumulative perpetual preferred stock,
$11.50 liquidation preference per share (the “Preferred Shares”) set forth below such Purchaser’s name on the signature page of this Agreement; and (iii) that aggregate number of shares of the Company’s Series C
non-voting mandatorily convertible cumulative perpetual preferred stock, $11.50 liquidation preference per share (the “Non-Voting Preferred Shares”) set forth below such Purchaser’s name on the signature page of this Agreement.
In addition to the Common Shares, Preferred Shares and Non-Voting Preferred Shares, (a) each Purchaser who purchases not less than $5 Million of Common Shares and/or Preferred Shares will receive, and the Company will issue and deliver, a
warrant to purchase nonvoting, mandatorily convertible, common shares of the Company (the “Non-Voting Common Stock”) in the form attached hereto as Exhibit “A” in an amount equal to fifty percent (50%) of the
aggregate number of Common Shares, Preferred Shares and Non-Voting Preferred Shares purchased by that Purchaser, at an exercise price of $11.50 for a term of five years, and (b) each Purchaser who purchases less than $5 Million of Common Shares
and/or Preferred Shares will receive, and the Company will issue and deliver, a warrant to purchase Non-Voting Common Stock in the form attached hereto as Exhibit “A” in an amount equal to twenty-five percent (25%) of the aggregate
number of Common Shares and Preferred Shares purchased by that Purchaser, at an exercise price of $11.50 for a term of five years (collectively, referred to herein as the “Warrants”). When purchased, the Preferred Shares and the
Non-Voting Preferred Shares will have the terms set forth in the articles of amendment in the form attached hereto as Exhibit “B” hereto (the “Certificate of Determination”) made part of the Company’s Articles of
Incorporation, as amended, by filing the Certificate of Determination with the Kentucky Secretary of State (the “Kentucky Secretary”) and will automatically convert into shares of the Company’s common stock, no par value,
subject to and in accordance with the terms and conditions of the Certificate of Determination. The Non-Voting Common Stock issuable upon exercise of the Warrants and the voting common shares issuable upon conversion of the

 
Preferred Shares and the Non-Voting Preferred Shares are collectively referred to herein as the “Underlying Shares,” and the Common Shares, Preferred Shares, Non-Voting Preferred
Shares, Warrants and Underlying Shares are collectively referred to herein as the “Securities.” 

C. Contemporaneously with the execution and delivery of this Agreement, the parties hereto are executing and delivering a
Registration Rights Agreement, substantially in the form attached hereto as Exhibit “C” (the “Registration Rights Agreement”), pursuant to which, among other things, the Company will agree to provide certain
registration rights with respect to the Securities under the Securities Act and the rules and regulations promulgated thereunder and applicable state securities laws. 

D. The Company has engaged Sandler O’Neill & Partners, L.P. as its exclusive placement agent (the “Placement
Agent”) for the offering of the Securities. 
 NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in
this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and the Purchasers hereby agree as follows: 

ARTICLE I. 

DEFINITIONS 

Definitions. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms shall
have the meanings indicated in this Article I: 
 “Action” means any action, suit, inquiry, notice of
violation, proceeding (including any partial proceeding such as a deposition) or investigation pending or, to the Company’s Knowledge, threatened in writing against the Company, any Subsidiary or any of their respective properties or any
officer, director or employee of the Company or any Subsidiary acting in his or her capacity as an officer, director or employee before or by any federal, state, county, local or foreign court, arbitrator, governmental or administrative agency,
regulatory authority, stock market, stock exchange or trading facility. 
 “Affiliate” means, with respect to
any Person, any other Person that, directly or indirectly through one or more intermediaries, Controls, is controlled by or is under common control with such Person, as such terms are used in and construed under Rule 405 under the Securities Act.
With respect to a Purchaser, any investment fund or managed account that is managed on a discretionary basis by the same investment manager as such Purchaser will be deemed to be an Affiliate of such Purchaser. 

“Agency” has the meaning set forth in Section 3.1(oo). 

“Agreement” shall have the meaning ascribed to such term in the Preamble. 

 

 2 

 “Articles of Incorporation” means the Articles of Incorporation of the
Company and all amendments thereto (including amendments authorizing series of preferred shares), as the same may be amended from time to time. 

“Bank” means the Company’s wholly owned subsidiary, PBI Bank, a Kentucky banking corporation. 

“Bank Board” has the meaning set forth in Section 4.19(h). 

“Bank Board Observer” has the meaning set forth in Section 4.19(h). 

“Bank Board Representative” has the meaning set forth in Section 4.19(h). 

“BHC Act” means the Bank Holding Company Act of 1956, as amended. 

“Blue Sky” has the meaning set forth in Section 4.4. 

“Board Observer” has the meaning set forth in Section 4.19(d). 

“Business Day” means a day, other than a Saturday or Sunday, on which banks in New York City are open for the general
transaction of business. 
 “Buy-In” has the meaning set forth in Section 4.1(e). 

“Buy-In Price” has the meaning set forth in Section 4.1(e). 

“Certificate of Determination” has the meaning set forth in the Recitals. 

“Closing” means the initial closing of the purchase and sale of the Securities pursuant to this Agreement. 

“Closing Date” means the Trading Day when all of the Transaction Documents have been executed and delivered by the
applicable parties thereto, and all of the conditions set forth in Sections 2.1, 2.2, 5.1 and 5.2 hereof are satisfied, or such other date as the parties may mutually agree. 

“Code” has the meaning set forth in Section 3.1(qq). 

“Commission” has the meaning set forth in the Recitals. 

“Common Shares” has the meaning set forth in the Recitals, and also includes any securities into which the Common Shares
may hereafter be reclassified or changed. 
 “Company” shall have the meaning ascribed to such term in the
Preamble. 
  

 3 

 “Company Counsel” means Frost Brown Todd LLC. 

“Company Deliverables” has the meaning set forth in Section 2.2(a). 

“Company Reports” has the meaning set forth in Section 3.1(kk). 

“Company’s Knowledge” means with respect to any statement made to the knowledge of the Company, that the statement
is based upon the actual knowledge of the executive officers of the Company having responsibility for the matter or matters that are the subject of the statement after reasonable investigation. 

“Control” (including the terms “controlling”, “controlled by” or “under common control
with”) means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise. 

“Deadline Date” has the meaning set forth in Section 4.1(e). 

“Designated Board Member” has the meaning set forth in Section 4.19(a). 

“DFI” means the Kentucky Department of Financial Institutions. 

“Disclosure Materials” has the meaning set forth in Section 3.1(h). 

“DTC” means The Depository Trust Company. 

“Effective Date” means the date on which the initial Registration Statement required by the terms hereof is first
declared effective by the Commission. 
 “Environmental Laws” has the meaning set forth in Section 3.1(l).

 “ERISA” has the meaning set forth in Section 3.1(qq). 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and
regulations promulgated thereunder. 
 “FDIC” means the Federal Deposit Insurance Corporation. 

“Federal Reserve” has the meaning set forth in Section 3.1(kk). 

“GAAP” means U.S. generally accepted accounting principles, as applied by the Company. 

 

 4 

 “Indemnified Person” has the meaning set forth in Section 4.8(b).

 “Insurer” has the meaning set forth in Section 3.1(oo). 

“Intellectual Property” has the meaning set forth in Section 3.1(r). 

“Kentucky Courts” means the state and federal courts sitting in the Commonwealth of Kentucky. 

“Kentucky Secretary” has the meaning set forth in the Recitals. 

“Lead Purchaser” has the meaning set forth in Section 4.19(a). 

“Legend Removal Date” has the meaning set forth in Section 4.1(c). 

“Lien” means any lien, charge, claim, encumbrance, security interest, right of first refusal, preemptive right or other
restrictions of any kind. 
 “Loan Investor” has the meaning set forth in Section 3.1(oo). 

“Material Adverse Effect” means, with respect to the Company, any change, circumstance or effect, individually or in the
aggregate, that (i) is, or is reasonably expected to be materially adverse to the business, results of operations, prospects, or condition (financial or otherwise), of the Company and its Subsidiaries taken as a whole, or (ii) could
materially impair the ability of the Company to perform its obligations under this Agreement or to consummate the Closing; provided, however, in determining whether a Material Adverse Effect has occurred, there shall be excluded any effect to
the extent resulting from the following: (A) changes, after the date hereof, in generally accepted accounting principles or regulatory accounting requirements applicable to financial institutions generally, except to the extent such change
disproportionately adversely affects the Company and its Subsidiaries, taken as a whole, (B) changes, after the date hereof, in laws of general applicability or interpretations thereof by courts or governmental authorities, (C) actions or
omissions by any party taken with the prior written permission of the other party or upon the recommendation of the other party or required under this Agreement, or (D) changes, after the date hereof, in global or national or regional political
conditions (including the outbreak of war or acts of terrorism) or in general or regional economic or market conditions affecting financial institutions or their holding companies generally except to the extent that any such changes in general or
regional economic or market conditions have a disproportionate adverse effect on such party. 
 “Material
Contract” means any contract of the Company that was filed as an exhibit to the SEC Reports on file as of the date of this Agreement pursuant to Item 601 of Regulation S-K. 

“Material Permits” has the meaning set forth in Section 3.1(p). 

 

 5 

 “Money Laundering Laws” has the meaning set forth in Section 3.1(ii).

 “New Security” has the meaning set forth in Section 4.15(a). 

“Non-Public Information” has the meaning set forth in Section 4.6. 

“Non-Voting Common Stock” has the meaning set forth in the Recitals. 

“Non-Voting Preferred Shares” has the meaning set forth in the Recitals. 

“Observer” has the meaning set forth in Section 4.19. 

“OFAC” means the Office of Foreign Assets Control of the U.S. Treasury Department. 

“Offering” has the meaning set forth in Section 4.15(b). 

“Outside Date” means the thirtieth day following the date of this Agreement; provided that if such day is not a Business
Day, the first day following such day that is a Business Day. 
 “Pension Plan” has the meaning set forth in
Section 3.1(qq). 
 “Person” means an individual, corporation, partnership, limited liability company,
trust, business trust, association, joint stock company, joint venture, sole proprietorship, unincorporated organization, governmental authority or any other form of entity not specifically listed herein. 

“Placement Agent” has the meaning set forth in the Recitals. 

“Preferred Shares” has the meaning set forth in the Recitals. 

“Press Release” has the meaning set forth in Section 4.6. 

“Principal Trading Market” means the Trading Market on which the common shares of the Company are primarily listed on
and quoted for trading, which, as of the date of this Agreement and the Closing Date, shall be the NASDAQ Global Market. 

“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation
or partial proceeding, such as a deposition), whether commenced or threatened. 
 “Prospectus” means the
prospectus included in any Registration Statement, as amended or supplemented by any prospectus supplement with respect to the terms of the offering of any portion of the Registrable Securities covered by such Registration Statement or any other
amendments and supplements to such prospectus, including without limitation any preliminary prospectus, any pre-effective or post-effective amendment and all material incorporated by reference in any prospectus. 

 

 6 

 “Purchase Price” means $11.50 per Common Share, per Preferred Share and per
Non-Voting Preferred Share. 
 “Purchaser” and “Purchasers” shall have the meaning ascribed to
such terms in the Preamble. 
 “Purchaser Deliverables” has the meaning set forth in Section 2.2(b).

 “Purchaser Party” has the meaning set forth in Section 4.8(a). 

“Registration Rights Agreement” has the meaning set forth in the Recitals. 

“Registration Statement” means a registration statement meeting the requirements set forth in the Registration Rights
Agreement and covering the resale by the Purchasers of the Registrable Securities (as defined in the Registration Rights Agreement). 

“Regulation D” has the meaning set forth in the Recitals. 

“Regulatory Agreement” has the meaning set forth in Section 3.1(mm). 

“Required Approvals” has the meaning set forth in Section 3.1(e). 

“Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be
amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. 

“SEC Reports” has the meaning set forth in Section 3.1(h). 

“Secretary’s Certificate” has the meaning set forth in Section 2.2(a)(iv). 

“Securities” has the meaning set forth in the Recitals. 

“Securities Act” means the Securities Act of 1933, as amended. 

“Shareholder Approvals” has the meaning set forth in Section 4.11. 

“Shareholder Proposal” has the meaning set forth in Section 4.11. 

“Significant Subsidiaries” has the meaning set forth in Section 3.1(b). 

“Stock Certificates” has the meaning set forth in Section 2.2(a)(ii). 

 

 7 

 “Subscription Amount” means with respect to each Purchaser, the aggregate
amount to be paid for the Securities purchased hereunder as indicated on such Purchaser’s signature page to this Agreement next to the heading “Aggregate Purchase Price (Subscription Amount)”. 

“Subsidiary” means any entity in which the Company, directly or indirectly, owns sufficient capital stock or holds a
sufficient equity or similar interest such that it is consolidated with the Company in the financial statements of the Company. 

“Trading Day” means (i) a day on which the Common Shares are listed or quoted and traded on its Principal Trading
Market (other than the OTC Bulletin Board), or (ii) if the Common Shares are not listed on a Trading Market (other than the OTC Bulletin Board), a day on which the Common Shares are traded in the over-the-counter market, as reported by the OTC
Bulletin Board, or (iii) if the Common Shares are not quoted on any Trading Market, a day on which the Common Shares is quoted in the over-the-counter market as reported in the “pink sheets” by Pink Sheets LLC (or any similar
organization or agency succeeding to its functions of reporting prices); provided , that in the event that the Common Shares are not listed or quoted as set forth in (i), (ii) and (iii) hereof, then Trading Day shall mean a Business
Day. 
 “Trading Market” means whichever of the New York Stock Exchange, the NYSE Amex, the NASDAQ Global
Select Market, the NASDAQ Global Market, the NASDAQ Global Market or the OTC Bulletin Board on which the Common Shares are listed or quoted for trading on the date in question. 

“Transaction Documents” means this Agreement, the Warrant, the schedules and exhibits attached hereto, the Certificate
of Determination, the Registration Rights Agreement and any other documents or agreements executed in connection with the transactions contemplated hereunder. 

“Transfer Agent” means American Stock Transfer & Trust Company or any successor transfer agent for the Company.

 “Underlying Shares” has the meaning set forth in the Recitals. 

“Warrants” has the meaning set forth in the Recitals. 

ARTICLE II. 

PURCHASE AND SALE 

2.1 Closing. 

(a) Purchase of Securities. Subject to the terms and conditions set forth in this Agreement, at the Closing the Company shall issue
and sell to each Purchaser, and each Purchaser shall, severally and not jointly, purchase from the Company, the number of Common 

 

 8 

 
Shares, Preferred Shares and Non-Voting Preferred Shares set forth below such Purchaser’s name on the signature page of this Agreement and, as entitled to as set forth in the second recital
of this Agreement, a Warrant to purchase the number of Underlying Shares set forth below such Purchaser’s name on the signature page of this Agreement. 

(b) Closing. The Closing of the purchase and sale of the Securities shall take place at the offices of the Company, 2500 Eastpoint
Parkway, Louisville, KY 40223, on the Closing Date or at such other locations or remotely by facsimile transmission or other electronic means as the parties may mutually agree and shall occur no later than the fifth Business Day following the
date on which the conditions to closing set forth in Article V are satisfied (other than those conditions that by their nature are to be satisfied at Closing but subject to the fulfillment or waiver of those conditions). 

(c) Delivery and Payment. At the Closing, the Company shall deliver to each of the respective Purchasers a certificate or
certificates for Common Shares, Preferred Shares, Non-Voting Preferred Shares and Warrants, in such reasonable denominations as the Purchaser may have designated in writing not less than three days before the Closing, and registered in the name of
the Purchaser (or its designee or nominee), representing the Securities the Purchaser is acquiring in the transaction. At the Closing, the Purchaser shall deliver the purchase price of his respective Subscription Amount in immediately available
funds by wire transfer to: 
  

			
	ABA Routing Number:	  	083903894
	Beneficiary:	  	Porter Bancorp, Inc.
	Acct #:	  	30009500
	Attn:	  	Maria L. Bouvette

 2.2 Closing Deliveries.

 (a) On or prior to the Closing, the Company shall issue, deliver or cause to be delivered to each Purchaser the following
(the “Company Deliverables”): 
  

	 	(i)	this Agreement, duly executed by the Company; 

  

	 	(ii)	one or more stock certificates (if physical certificates are required by the Purchaser to be held immediately prior to Closing; if not, then facsimile or
“.pdf” copies of such certificates shall suffice for purposes of Closing with the original stock certificates to be delivered within three Business Days of the Closing Date) and warrants evidencing the Securities subscribed for by
Purchaser hereunder, registered in the name of such Purchaser or as otherwise set forth on the Investor Questionnaire included as Exhibit “D”, hereto, (the “Stock Certificates”) (or, if the Company and such Purchaser
agree, the Company shall cause to be made a book-entry record through the facilities of DTC representing the Common Shares, Preferred Shares and Non-Voting Preferred Shares registered in the name of such Purchaser or as otherwise set forth on the
Investor Questionnaire); 

  

 9 

	 	(iii)	a legal opinion of Company Counsel, dated as of the Closing Date and in the form attached hereto as Exhibit “E”, executed by such counsel and addressed to the
Purchasers; and 

  

	 	(iv)	a certificate of the Secretary of the Company, in the form attached hereto as Exhibit “F” (the “Secretary’s Certificate”), dated as of
the Closing Date, (a) certifying the resolutions adopted by the Board of Directors of the Company or a duly authorized committee thereof approving the transactions contemplated by this Agreement and the other Transaction Documents and the
issuance of the Securities, (b) certifying the current versions of the articles of incorporation, as amended, and by-laws, as amended, of the Company and (c) certifying as to the signatures and authority of persons signing the Transaction
Documents and related documents on behalf of the Company; 

  

	 	(v)	the Compliance Certificate referred to in Section 5.1(g); and 

  

	 	(vi)	a certificate evidencing the good standing of each of the Company and PBI Bank in its respective jurisdiction of formation issued by the Secretary of State (or
comparable office) of such jurisdiction, as of a date within five (5) business days of the Closing Date. 

(b) On or prior to the Closing, each Purchaser shall deliver or cause to be delivered to the Company the following (the
“Purchaser Deliverables”): 
  

	 	(i)	this Agreement, duly executed by such Purchaser; and 

  

	 	(ii)	its Subscription Amount, in U.S. dollars and in immediately available funds, in the amount indicated below such Purchaser’s name on the applicable signature page
hereto under the heading “Aggregate Purchase Price (Subscription Amount)” by wire transfer in accordance with the Company’s written instructions. 

ARTICLE III. 

REPRESENTATIONS AND WARRANTIES 

3.1 Representations and Warranties of the Company. The Company hereby represents and warrants as of the date hereof and the Closing
Date (except for the representations and warranties that speak as of a specific date, which shall be made as of such date), to each of the Purchasers that: 

(a) Subsidiaries. The Company has no direct or indirect Subsidiaries other than those listed in Schedule 3.1(a) hereto.
Except as disclosed in Schedule 3.1(a) hereto, the Company owns, directly or indirectly, all of the capital stock or comparable equity interests of each Subsidiary free and clear of any and all Liens, and all the issued and outstanding
shares of capital stock or comparable equity interest of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. 

 

 10 

 (b) Organization and Qualification. The Company and each of its “Significant
Subsidiaries” (as defined in Rule 1-02 of Regulation S-X) is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization (as applicable), with
the requisite power and authority to own or lease and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Significant Subsidiary is in violation of any of the provisions of its
respective certificate or articles of incorporation, bylaws or other organizational or charter documents. The Company and each of its Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, would not have a Material
Adverse Effect. The Company is duly registered as a bank holding company under the BHC Act. The Bank’s deposit accounts are insured up to applicable limits by the Federal Deposit Insurance Corporation, and all premiums and assessments
required to be paid in connection therewith have been paid when due. The Company and each Significant Subsidiary has conducted its business in compliance with all applicable federal, state and foreign laws, orders, judgments, decrees, rules,
regulations and applicable stock exchange requirements, including all laws and regulations restricting activities of bank holding companies and banking organizations, except for any noncompliance that, individually or in the aggregate, has not had
and would not be reasonably expected to have a Material Adverse Effect. 
 (c) Authorization; Enforcement; Validity. The
Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by each of the Transaction Documents to which it is a party and otherwise to carry out its obligations hereunder and thereunder,
including, without limitation, to issue the Securities in accordance with the terms hereof. The Company’s execution and delivery of each of the Transaction Documents to which it is a party and the consummation by it of the transactions
contemplated hereby and thereby (including, but not limited to, the sale and delivery of the Securities) have been duly authorized by all necessary corporate action on the part of the Company, and no further corporate action is required by the
Company, its Board of Directors or its shareholders in connection therewith other than in connection with the Shareholder Approvals. Each of the Transaction Documents to which it is a party has been (or upon delivery will have been) duly executed by
the Company and is, or when delivered in accordance with the terms hereof, will constitute the legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as such enforceability
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar 
  

 11 

 
laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general application, (ii) as limited by laws relating to
the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law. Except for Material Contracts, there are no shareholder
agreements, voting agreements, or other similar arrangements with respect to the Company’s capital stock to which the Company is a party or, to the Company’s Knowledge, between or among any of the Company’s shareholders. 

(d) No Conflicts. The execution, delivery and performance by the Company of the Transaction Documents to which it is a party and the
consummation by the Company of the transactions contemplated hereby or thereby (including, without limitation, the issuance and delivery of the Securities) do not and will not (i) conflict with or violate any provisions of the Company’s or
any Subsidiary’s certificate or articles of incorporation, bylaws or otherwise result in a violation of the organizational documents of the Company or any Subsidiary, (ii) conflict with, or constitute a default (or an event that with
notice or lapse of time or both would result in a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or give to others any rights of termination, amendment, acceleration or cancellation (with or
without notice, lapse of time or both) of, any Material Contract, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any
court or governmental authority to which the Company is subject (including federal and state securities laws and regulations and the rules and regulations, assuming the correctness of the representations and warranties made by the Purchasers herein,
of any self-regulatory organization to which the Company or its securities are subject, including all applicable Trading Markets), or by which any property or asset of the Company is bound or affected, except in the case of clauses (ii) and
(iii) such as would not have or reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. 

(e) Filings, Consents and Approvals. Neither the Company nor any of its Subsidiaries is required to obtain any consent, waiver,
authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the
Company of the Transaction Documents (including, without limitation, the issuance of the Securities) other than (i) obtaining Shareholder Approvals, (ii) the filing of the Certificate of Determination with the Kentucky Secretary,
(iii) the filing with the Commission of one or more Registration Statements in accordance with the requirements set forth herein, (iv) filings required by applicable state securities laws, (v) the filing of a Notice of Sale of
Securities on Form D with the Commission under Regulation D of the Securities Act, (vi) the filing of any requisite notices and/or application(s) to the Principal Trading Market for the issuance and sale of the Common Shares and the
Underlying Shares and the listing of the Common Shares and the Underlying Shares for trading or quotation, as the case may be, thereon in the time and manner required thereby, (vii) the filings required in accordance with Section 4.6 of
this Agreement, and (viii) those that have been made or obtained prior to the date of this Agreement (collectively, the “Required Approvals”). 

 

 12 

 (f) Issuance of the Shares. The issuance of the Securities and the reservation of
Underlying Shares have been duly authorized. The Common Shares, Preferred Shares and Non-Voting Preferred Shares, when issued and paid for in accordance with the terms of the Transaction Documents, will be duly and validly issued, fully paid and
non-assessable and free and clear of all Liens, other than restrictions on transfer provided for in the Transaction Documents or imposed by applicable securities laws, and shall not be subject to preemptive or similar rights. The issuance of
the Underlying Shares has been duly authorized and the Underlying Shares will be duly and validly issued, fully paid and non-assessable and free and clear of all Liens, other than restrictions on transfer provided for in the Transaction Documents or
imposed by applicable securities laws, and shall not be subject to preemptive or similar rights. Assuming the accuracy of the representations and warranties of the Purchasers in this Agreement, the Securities will be issued in compliance with
all applicable federal and state securities laws. 
 (g) Capitalization. The number of shares and type of all authorized,
issued and outstanding capital stock, options and other securities of the Company (whether or not presently convertible into or exercisable or exchangeable for shares of capital stock of the Company) is set forth in Schedule 3.1(g). All
of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and non-assessable, have been issued in compliance in all material respects with all applicable federal and state securities laws, and none of
such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase any capital stock of the Company. Except as set forth in Schedule 3.1(g): (i) no shares of the Company’s
outstanding capital stock are subject to preemptive rights or any other similar rights; (ii) there are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities
or rights convertible into, or exercisable or exchangeable for, any shares of capital stock of the Company, or contracts, commitments, understandings or arrangements by which the Company is or may become bound to issue additional shares of capital
stock of the Company or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares of capital stock of the
Company, other than those issued or granted pursuant to Material Contracts or equity or incentive plans or arrangements described in the SEC Reports as of the date of this Agreement; (iii) there are no material outstanding debt securities,
notes, credit agreements, credit facilities or other agreements, documents or instruments evidencing indebtedness of the Company or by which the Company is bound; (iv) except for registration obligations set forth herein, there are no
agreements or arrangements under which the Company is obligated to register the sale of any of its securities under the Securities Act; (v) there are no outstanding securities or instruments of the Company that contain any redemption or similar
provisions, and there are no contracts, commitments, understandings or arrangements by which the Company is or may become bound to redeem a security of the Company; (vi) the Company does not have any stock appreciation rights or “phantom
stock” plans or agreements or any similar plan or agreement; and (vii) the Company has no liabilities or obligations required to be disclosed in the SEC Reports but not so disclosed in the SEC Reports as of the date of this Agreement,
which, individually or in the aggregate, will have or would reasonably be expected to have a Material Adverse Effect. There are no securities or instruments containing anti-dilution or similar provisions that will be triggered by the issuance
of the Securities. 
  

 13 

 (h) SEC Reports; Disclosure Materials. The Company has filed all reports, schedules,
forms, statements and other documents required to be filed by it under the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, since December 31, 2008 (the foregoing materials, including the exhibits thereto and documents
incorporated by reference therein, being collectively referred to herein as the “SEC Reports” and together with this Agreement and the Schedules to this Agreement, the “Disclosure Materials”), on a timely basis or
has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective filing dates, the SEC Reports complied in all material respects with the requirements of
the Securities Act and the Exchange Act and the rules and regulations of the Commission promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. 

(i) Financial Statements. The financial statements of the Company included in the SEC Reports comply in all material respects with
applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with GAAP applied on a consistent basis during the
periods involved, except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the
balance sheet of the Company and its consolidated subsidiaries taken as a whole as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal,
year-end audit adjustments, which would not be material, either individually or in the aggregate. 
 (j) Tax Matters. The
Company (i) has prepared and filed all foreign, federal and state income and all other tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments
and charges that are material in amount, shown or determined to be due on such returns, reports and declarations, except those being contested in good faith, with respect to which adequate reserves have been set aside on the books of the Company and
(iii) has set aside on its books provisions reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply, except where the failure to take such action would not have
or reasonably be expected to have a Material Adverse Effect. 
 (k) Material Changes. Since the date of the latest audited
financial statements included within the SEC Reports filed prior to the date of this Agreement, except as disclosed in subsequent SEC Reports filed prior to the date of this Agreement, the businesses of the Company and its Significant Subsidiaries
have been conducted only in the ordinary course, in substantially the same manner as theretofore conducted, and there has not occurred since December 31, 2008, any event that has had a Material Adverse Effect. 

 

 14 

 (l) Environmental Matters. Neither the Company nor any of its Subsidiaries (i) is
in violation of any statute, rule, regulation, decision or order of any governmental agency or body or any court, domestic or foreign, relating to the use, disposal or release of hazardous or toxic substances or relating to the protection or
restoration of the environment or human exposure to hazardous or toxic substances (collectively, “Environmental Laws”), (ii) owns or operates any real property contaminated with any substance that is in violation of any
Environmental Laws, (iii) is liable for any off-site disposal or contamination pursuant to any Environmental Laws, or (iv) is subject to any claim relating to any Environmental Laws; in each case, which violation, contamination, liability
or claim has had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect; and, to the Company’s Knowledge, there is no pending or threatened investigation that might lead to such a claim. 

(m) Litigation. There is no Action which (i) adversely affects or challenges the legality, validity or enforceability of any of
the Transaction Documents or the Securities or (ii) except as disclosed in the SEC Reports as of the date of this Agreement, is reasonably likely to have a Material Adverse Effect, individually or in the aggregate, if there were an unfavorable
decision. Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary
duty. There has not been, and to the Company’s Knowledge there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission has
not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any of its Subsidiaries under the Exchange Act or the Securities Act. 

(n) Employment Matters. No material labor dispute exists or, to the Company’s Knowledge, is imminent with respect to any of the
employees of the Company which would have or reasonably be expected to have a Material Adverse Effect. None of the Company’s employees is a member of a union that relates to such employee’s relationship with the Company, and neither the
Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and each Subsidiary believes that its relationship with its employees is good. To the Company’s Knowledge, no executive officer is, or is
now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor
of a third party, and to the Company’s Knowledge, the continued employment of each such executive officer does not subject the Company or any Subsidiary to any liability with respect to any of the foregoing matters. The Company is in
compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance would not have or
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. 
 (o) Compliance. Neither the
Company nor any of its Subsidiaries (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any of its

  

 15 

 
Subsidiaries under), nor has the Company or any of its Subsidiaries received written notice of a claim that it is in default under or that it is in violation of, any Material Contract (whether or
not such default or violation has been waived), (ii) is in violation of any order of any court, arbitrator or governmental body having jurisdiction over the Company or its properties or assets, or (iii) is in violation of, or in receipt of
written notice that it is in violation of, any statute, rule, regulation, policy or guidelines or order of any governmental authority applicable to the Company or any of its Subsidiaries, or which would have the effect of revoking or limiting FDIC
deposit insurance, except in each case as would not have or reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. 

(p) Regulatory Permits. The Company and each of its Subsidiaries possess or have applied for all certificates, authorizations and
permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as conducted and as described in the SEC Reports on file as of the date of this Agreement, except where the
failure to possess such permits, individually or in the aggregate, has not and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect (“Material Permits”), and (i) neither the
Company nor any of its Subsidiaries has received any notice in writing of proceedings relating to the revocation or material adverse modification of any such Material Permits and (ii) the Company is unaware of any facts or circumstances that
would give rise to the revocation or material adverse modification of any Material Permits. 
 (q) Title to Assets. The
Company and its Subsidiaries have good and marketable title to all real property and tangible personal property owned by them which is material to the business of the Company and its Subsidiaries, taken as a whole, in each case free and clear of all
Liens except such as do not materially affect the value of such property or do not interfere with the use made and proposed to be made of such property by the Company and any of its Subsidiaries. Any real property and facilities held under lease by
the Company and any of its Subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings by the
Company and its Subsidiaries. 
 (r) Patents and Trademarks. The Company and its Subsidiaries own, possess, license or have
other rights to use all foreign and domestic patents, patent applications, trade and service marks, trade and service mark registrations, trade names, copyrights, inventions, trade secrets, technology, Internet domain names, know-how and other
intellectual property (collectively, the “Intellectual Property”) necessary for the conduct of their respective businesses as now conducted or as proposed to be conducted as disclosed in the SEC Reports on file as of the date of
this Agreement except where the failure to own, possess, license or have such rights would not have or reasonably be expected to have a Material Adverse Effect. Except as set forth in the SEC Reports on file as of the date of this Agreement and
except where such violations or infringements would not have or reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect, (a) there are no rights of third parties to any such Intellectual Property;
(b) there is no infringement by third parties of any such Intellectual Property; (c) there is no pending or threatened action, suit, proceeding or claim by others challenging the Company’s and its Subsidiaries’ rights in or to
any such Intellectual Property; (d)
  

 16 

 
there is no pending or threatened action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property; and (e) there is no pending or threatened
action, suit, proceeding or claim by others that the Company and/or any Subsidiary infringes or otherwise violates any patent, trademark, copyright, trade secret or other proprietary rights of others. 

(s) Insurance. The Company and each of the Subsidiaries are insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as the Company believes to be prudent and customary in the businesses and locations in which the Company and the Subsidiaries are engaged. Neither the Company nor any of its Subsidiaries has received any
notice of cancellation of any such insurance, nor, to the Company’s Knowledge, will it or any Subsidiary be unable to renew their respective existing insurance coverage as and when such coverage expires or to obtain similar coverage from
similar insurers as may be necessary to continue its business at a cost that would not have a Material Adverse Effect. 
 (t)
Transactions With Affiliates and Employees. Except as set forth in the SEC Reports on file as of the date of this Agreement and other than the grant of stock options or other equity awards that are not individually or in the aggregate material
in amount, none of the officers or directors of the Company and, to the Company’s Knowledge, none of the employees of the Company, is presently a party to any transaction with the Company or to a presently contemplated transaction (other than
for services as employees, officers and directors) that would be required to be disclosed pursuant to Item 404 of Regulation S-K promulgated under the Securities Act. 

(u) Internal Control Over Financial Reporting. Except as set forth in the SEC Reports on file as of the date of this Agreement, the
Company maintains internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted accounting principles and such internal control over financial reporting is effective. 

(v) Sarbanes-Oxley; Disclosure Controls. The Company is in compliance in all material respects with all of the provisions of the
Sarbanes-Oxley Act of 2002 which are applicable to it. Except as disclosed in the SEC Reports on file as of the date hereof, the Company maintains disclosure controls and procedures (as such term is defined in Rule 13a 15(e) and 15d-15(e) under
the Exchange Act), and such disclosure controls and procedures are effective. 
 (w) Certain Fees. No person or entity will
have, as a result of the transactions contemplated by this Agreement, any valid right, interest or claim against or upon the Company or a Purchaser for any commission, fee or other compensation pursuant to any agreement, arrangement or understanding
entered into by or on behalf of the Company, other than the Placement Agent with respect to the offer and sale of the Shares (which placement agent fees are being paid by the Company). The Company shall indemnify, pay, and hold each Purchaser
harmless against, any liability, loss or expense (including, without limitation, attorneys’ fees and out-of-pocket expenses) arising in connection with any such right, interest or claim. 

 

 17 

 (x) Private Placement. Assuming the accuracy of the Purchasers’ representations
and warranties set forth in Section 3.2 of this Agreement and the accuracy of the information disclosed in the Investor Questionnaires, no registration under the Securities Act is required for the offer and sale of the Securities by the Company
to the Purchasers under the Transaction Documents. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Principal Trading Market. 

(y) Registration Rights. Other than each of the Purchasers, except as set forth on Schedule 3.1(y), no Person has any right
to cause the Company to effect the registration under the Securities Act of any securities of the Company other than those securities which are currently registered on an effective registration statement on file with the Commission. 

(z) No Integrated Offering. Assuming the accuracy of the Purchasers’ representations and warranties set forth in
Section 3.2, none of the Company, its Subsidiaries nor, to the Company’s Knowledge, any of its Affiliates or any Person acting on its behalf has, directly or indirectly, at any time within the past six months, made any offers or sales of
any Company security or solicited any offers to buy any security under circumstances that would eliminate the availability of the exemption from registration under Regulation D under the Securities Act in connection with the offer and sale by
the Company of the Securities as contemplated hereby. 
 (aa) Listing and Maintenance Requirements. The Company’s
common shares are registered pursuant to Section 12(b) of the Exchange Act, and the Company has taken no action designed to terminate the registration of the Common Shares under the Exchange Act nor has the Company received any notification
that the Commission is contemplating terminating such registration. The Company has not, in the 12 months preceding the date hereof, received written notice from any Trading Market on which the common shares are listed or quoted to the effect
that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance in all material
respects with the listing and maintenance requirements for continued trading of the common shares on the Principal Trading Market. 

(bb) Investment Company. Neither the Company nor any of its Subsidiaries is required to be registered as, and is not an Affiliate
of, and immediately following the Closing will not be required to register as, an “investment company” within the meaning of the Investment Company Act of 1940, as amended. 

(cc) Questionable Payments. Neither the Company nor any of its Subsidiaries, nor any directors, officers, nor to the Company’s
Knowledge, employees, agents or other Persons acting at the direction of or on behalf of the Company or any of its Subsidiaries has, in the course of its actions for, or on behalf of, the Company: (a) directly or indirectly, used any corporate

  

 18 

 
funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to foreign or domestic political activity; (b) made any direct or indirect unlawful payments to any
foreign or domestic governmental officials or employees or to any foreign or domestic political parties or campaigns from corporate funds; (c) violated any provision of the Foreign Corrupt Practices Act of 1977, as amended, or (d) made any
other unlawful bribe, rebate, payoff, influence payment, kickback or other material unlawful payment to any foreign or domestic government official or employee. 

(dd) Application of Takeover Protections; Rights Agreements. The Company has not adopted any shareholder rights plan or similar
arrangement relating to accumulations of beneficial ownership of Common Shares or a change in control of the Company.
 (ee) Off
Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its
Exchange Act filings and is not so disclosed and would have or reasonably be expected to have a Material Adverse Effect. 
 (ff)
Acknowledgment Regarding Purchasers’ Purchase of Securities. The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and
the transactions contemplated hereby and thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the
transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental to the
Purchasers’ purchase of the Securities. 
 (gg) Absence of Manipulation. The Company has not, and to the
Company’s Knowledge no one acting on its behalf has, taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of
any of the Securities. 
 (hh) OFAC. Neither the Company nor any Subsidiary nor, to the Company’s Knowledge, any
director, officer, agent, employee, Affiliate or Person acting on behalf of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department
(“OFAC”); and the Company will not knowingly directly or indirectly use the proceeds of the sale of the Securities, or lend, contribute or otherwise make available such proceeds to any Subsidiary, joint venture partner or other
Person or entity, towards any sales or operations in Cuba, Iran, Syria, Sudan, Myanmar or any other country sanctioned by OFAC or for the purpose of financing the activities of any Person currently subject to any U.S. sanctions administered by OFAC.

 (ii) Money Laundering Laws. The operations of each of the Company and any Subsidiary are and have been conducted at all
times in compliance with the money 
  

 19 

 
laundering statutes of applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any
applicable governmental agency (collectively, the “Money Laundering Laws”), except where the failure to be in compliance would not have or reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect,
and to the Company’s Knowledge, no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company and/or any Subsidiary with respect to the Money Laundering Laws is pending or
threatened. 
 (jj) No Additional Agreements. The Company does not have any agreement or understanding with any Purchaser
with respect to the transactions contemplated by the Transaction Documents other than as specified in the Transaction Documents. 

(kk) Reports, Registrations and Statements. Since January 1, 2008, the Company and each Subsidiary have filed all material
reports, registrations and statements, together with any required amendments thereto, that it was required to file with the Board of Governors of the Federal Reserve System (the “Federal Reserve”), the FDIC, the DFI, and any other
applicable federal or state securities or banking authorities, except where the failure to file any such report, registration or statement would not have or reasonably be expected to have a Material Adverse Effect. All such reports and statements
filed with any such regulatory body or authority are collectively referred to herein as the “Company Reports.” As of their respective dates, the Company Reports complied as to form in all material respects with all the rules and
regulations promulgated by the Federal Reserve, the FDIC, the DFI and any other applicable foreign, federal or state securities or banking authorities, as the case may be. 

(ll) Adequate Capitalization. As of December 31, 2009, the Company’s Subsidiary insured depository institution meets or
exceeds the standards necessary to be considered “well capitalized” under the Federal Deposit Insurance Company’s regulatory framework for prompt corrective action. 

(mm) Agreements with Regulatory Agencies; Compliance with Certain Banking Regulations. Except as disclosed in Schedule
3.1(mm), neither the Company nor any Subsidiary is subject to any cease-and-desist or other similar order or enforcement action issued by, or is a party to any written agreement, consent agreement or memorandum of understanding with, or is a
party to any commitment letter, or is subject to any capital directive by, or since December 31, 2008, has adopted any board resolutions at the request of, any governmental entity that currently restricts in any material respect the conduct of
its business or that in any material manner relates to its capital adequacy, its liquidity and funding policies and practices, its ability to pay dividends, its credit, risk management or compliance policies, its internal controls, its management or
its operations or business (each item in this sentence, a “Regulatory Agreement”), nor has the Company or any Subsidiary been advised since December 31, 2008 by any governmental entity that it is considering issuing,
initiating, ordering, or requesting any such Regulatory Agreement. With respect to any matters requiring Board action prior to the date of this Agreement or Closing, as applicable, that were set forth in writing by any of the Federal Reserve,
the FDIC or the DFI, the Company and its Subsidiaries have addressed such matters in all material respects. 
  

 20 

 The Company has no knowledge of any facts and circumstances, and has no reason to believe
that any facts or circumstances exist, that would cause the Bank: (i) to be deemed not to be in satisfactory compliance with the Community Reinvestment Act and the regulations promulgated thereunder or to be assigned a CRA rating by federal or
state banking regulators of lower than “satisfactory”; (ii) to be deemed to be operating in violation, in any material respect, of the Bank Secrecy Act, the Patriot Act, any order issued with respect to anti-money laundering by the
OFAC, or any other anti-money laundering statute, rule or regulation; or (iii) to be deemed not to be in satisfactory compliance, in any material respect, with all applicable privacy of customer information requirements contained in any federal
and state privacy laws and regulations as well as the provisions of all information security programs adopted by the Subsidiaries. 

Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, each of the Company and
each Subsidiary has properly administered all accounts for which it acts as a fiduciary, including accounts for which it serves as a trustee, agent, custodian, personal representative, guardian, conservator or investment advisor, in accordance with
the terms of the governing documents, applicable federal and state law and regulation and common law. None of the Company, any Subsidiary or any director, officer or employee of the Company or any Subsidiary has committed any breach of trust or
fiduciary duty with respect to any such fiduciary account that would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect and, except as would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, the accountings for each such fiduciary account are true and correct and accurately reflect the assets of such fiduciary account. 

(nn) No General Solicitation or General Advertising. Neither the Company nor any person acting on its behalf has engaged or will
engage in any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection with any offer or sale of the Securities. 

(oo) Mortgage Banking Business. Except as has not had and would not reasonably be expected to have a Material Adverse Effect:

 (i) The Company and each of its Subsidiaries has complied with, and all documentation in connection with the
origination, processing, underwriting and credit approval of any mortgage loan originated, purchased or serviced by the Company or any of its Subsidiaries satisfied, (A) all applicable federal, state and local laws, rules and regulations with
respect to the origination, insuring, purchase, sale, pooling, servicing, subservicing, or filing of claims in connection with mortgage loans, including all laws relating to real estate settlement procedures, consumer credit protection, truth in
lending laws, usury limitations, fair housing, transfers of servicing, collection practices, equal credit opportunity and adjustable rate mortgages, (B) the responsibilities and obligations

  

 21 

 
relating to mortgage loans set forth in any agreement between the Company or any of its Subsidiaries and any Agency, Loan Investor or Insurer, (C) the applicable rules, regulations,
guidelines, handbooks and other requirements of any Agency, Loan Investor or Insurer and (D) the terms and provisions of any mortgage or other collateral documents and other loan documents with respect to each mortgage loan; and 

(ii) No Agency, Loan Investor or Insurer has (A) claimed in writing that the Company or any of its Subsidiaries has
violated or has not complied with the applicable underwriting standards with respect to mortgage loans sold by the Company or any of its Subsidiaries to a Loan Investor or Agency, or with respect to any sale of mortgage servicing rights to a Loan
Investor, (B) imposed in writing restrictions on the activities (including commitment authority) of the Company or any of its Subsidiaries or (C) indicated in writing to the Company or any of its Subsidiaries that it has terminated or
intends to terminate its relationship with the Company or any of its Subsidiaries for poor performance, poor loan quality or concern with respect to the Company’s or any of its Subsidiaries’ compliance with laws. 

For purposes of this Section 3.1(oo): (A) “Agency” means the Federal Housing Administration, the Federal Home Loan
Mortgage Corporation, the Farmers Home Administration (now known as Rural Housing and Community Development Services), the Federal National Mortgage Association, the Federal National Mortgage Association, the U.S. Department of Veterans’
Affairs, the Rural Housing Service of the U.S. Department of Agriculture or any other federal or state agency with authority to (i) determine any investment, origination, lending or servicing requirements with regard to mortgage loans
originated, purchased or serviced by the Company or any of its Subsidiaries or (ii) originate, purchase, or service mortgage loans, or otherwise promote mortgage lending, including state and local housing finance authorities;
(B) “Loan Investor” means any person (including an Agency) having a beneficial interest in any mortgage loan originated, purchased or serviced by the Company or any of its Subsidiaries or a security backed by or representing an
interest in any such mortgage loan; and (C) “Insurer” means a person who insures or guarantees for the benefit of the mortgagee all or any portion of the risk of loss upon borrower default on any of the mortgage loans originated,
purchased or serviced by the Company or any of its Subsidiaries, including the Federal Housing Administration, the United States Department of Veterans’ Affairs, the Rural Housing Service of the U.S. Department of Agriculture and any private
mortgage insurer, and providers of hazard, title or other insurance with respect to such mortgage loans or the related collateral. 

(pp) Risk Management Instruments. Except as has not had or would not reasonably be expected to have a Material Adverse Effect, since
January 1, 2008, all material derivative instruments, including, swaps, caps, floors and option agreements, whether entered into for the Company’s own account, or for the account of one or more of the Company Subsidiaries, were entered
into (1) only in the ordinary course of business, (2) in accordance with prudent practices and in all material respects with all applicable laws, rules, regulations and regulatory policies and (3) with counterparties believed to be
financially responsible at the time; 
  

 22 

 
and each of them constitutes the valid and legally binding obligation of the Company or one of the Company Subsidiaries, enforceable in accordance with its terms. Neither the Company or the
Company Subsidiaries, nor, to the knowledge of the Company, any other party thereto, is in breach of any of its material obligations under any such agreement or arrangement. 

(qq) ERISA. The Company is in compliance in all material respects with all presently applicable provisions of the Employee
Retirement Income Security Act of 1974, as amended, including the regulations and published interpretations thereunder (herein called “ERISA”); no “reportable event” (as defined in ERISA) has occurred with respect to any
“pension plan” (as defined in ERISA) for which the Company would have any liability; the Company has not incurred and does not expect to incur liability under (i) Title IV of ERISA with respect to termination of, or withdrawal from,
any “pension plan”; or (ii) Sections 412 or 4971 of the Internal Revenue Code of 1986, as amended, including the regulations and published interpretations thereunder (the “Code”); and each “Pension Plan” for
which the Company would have liability that is intended to be qualified under Section 401(a) of the Code is so qualified in all material respects and nothing has occurred, whether by action or by failure to act, which would cause the loss of
such qualification. 
 (rr) Shell Company Status. The Company is not, and has never been, an issuer identified in Rule
144(i)(1). 
 (ss) Reservation of Underlying Shares. The Company has reserved, free of any preemptive or similar rights of
shareholders of the Company, a number of unissued shares of nonvoting common shares, sufficient to issue and deliver the Underlying Shares for which the Warrants are exercisable and shares of voting common stock for which the Preferred Shares and
the Non-Voting Preferred Shares are convertible into. 
 (tt) Regulatory Capital Levels. At the Closing Date, taking into
account the proceeds of the capital raise contemplated as part of this Transaction and assuming the net proceeds this capital raise are contributed by Company to PBI Bank in accordance with Section 4.10, both the Company and PBI Bank will
have a Tier 1 capital at a level equal to or exceeding 9 percent of total assets, and total risk-based capital at a level equal to or exceeding 12 percent of total risk-based assets. 

(uu) Loan Loss Reserves. As of the date hereof and as of the Closing Date, the Company’s management has concluded that the loan
loss reserves of PBI Bank are adequate. 
 (vv) Change in Control. Except as disclosed on Schedule 3.1(vv), the
issuance of the Securities to the Purchasers as contemplated by this Agreement will not trigger any rights under any “change of control” provision in any of the agreements to which the Company or any of its Subsidiaries is a party,
including any employment, “change in control,” severance or other compensatory agreements and any benefit plan, which results in payments to the counterparty or the acceleration of vesting of benefits. 

 

 23 

 3.2 Representations and Warranties of the Purchasers. Each Purchaser, severally and not
jointly, hereby, for itself and for no other Purchaser, represents and warrants as of the date hereof and as of the Closing Date to the Company as follows: 

(a) Organization; Authority. If such Purchaser is an entity, it is duly organized, validly existing and in good standing under the
laws of the jurisdiction of its organization with the requisite corporate or partnership power and authority to enter into and to consummate the transactions contemplated by the applicable Transaction Documents and otherwise to carry out its
obligations hereunder and thereunder. If such Purchaser is an entity, the execution, delivery and performance by such Purchaser of the transactions contemplated by this Agreement have been duly authorized by all necessary corporate or, if such
Purchaser is not a corporation, such partnership, limited liability company or other applicable like action, on the part of such Purchaser. If such Purchaser is an entity, this Agreement has been duly executed by such Purchaser, and when delivered
by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except as such enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general application. 

(b) No Conflicts. The execution, delivery and performance by such Purchaser of this Agreement and the consummation by such Purchaser
of the transactions contemplated hereby will not (i) result in a violation of the organizational documents of such Purchaser (if such Purchaser is an entity), (ii) conflict with, or constitute a default (or an event which with notice or
lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which such Purchaser is a party, or (iii) result in a
violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws) applicable to such Purchaser, except in the case of clauses (ii) and (iii) above, for such conflicts, defaults, rights or
violations which would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the ability of such Purchaser to perform its obligations hereunder. 

(c) Investment Intent. Such Purchaser understands that the Common Shares, the Preferred Shares, the Non-Voting Preferred Shares and
the Warrant are, and the Underlying Shares will be, “restricted securities” and have not been registered under the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and
not with a view to, or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities laws, provided, however, that by making the representations herein, such Purchaser
does not agree to hold any of the Common Shares, the Preferred Shares, the Non-Voting Preferred Shares or Underlying Shares for any minimum period of time and reserves the right at all times to sell or otherwise dispose of all or any part of the
Common Shares, the Preferred Shares, the Non-Voting Preferred Shares or Underlying Shares pursuant to an effective registration statement under the Securities Act or under an exemption from such registration and in compliance with applicable federal
and state securities laws, and, if applicable, any regulations or policies of the Federal Reserve. Such 
  

 24 

 
Purchaser is acquiring the Securities hereunder in the ordinary course of its business. Such Purchaser does not presently have any agreement, plan or understanding, directly or indirectly, with
any Person to distribute or effect any distribution of any of the Common Shares, the Preferred Shares, the Non-Voting Preferred Shares and Underlying Shares to or through any person or entity. 

(d) Purchaser Status. At the time such Purchaser was offered the Securities, it was, and at the date hereof it is, an
“accredited investor” as defined in Rule 501(a) under the Securities Act. 
 (e) General Solicitation. Such
Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication regarding the Securities Shares published in any newspaper, magazine or similar media or broadcast over television or radio or
presented at any seminar or any other general advertisement. 
 (f) Experience of Such Purchaser. Such Purchaser, either
alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so
evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment. 

(g) Access to Information. Such Purchaser acknowledges that it has received and reviewed the Disclosure Materials and has been
afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of
investing in the Securities; (ii) access to information about the Company and the Subsidiaries and their respective financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate
its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the
investment. Neither such inquiries nor any other investigation conducted by or on behalf of such Purchaser or its representatives or counsel shall modify, amend or affect such Purchaser’s right to rely on the truth, accuracy and completeness of
the Disclosure Materials and the Company’s representations and warranties contained in the Transaction Documents. Such Purchaser has sought such accounting, legal and tax advice as it has considered necessary to make an informed decision with
respect to its acquisition of the Securities. 
 (h) Brokers and Finders. Other than the Placement Agent with respect to
the Company, no Person will have, as a result of the transactions contemplated by this Agreement, any valid right, interest or claim against or upon the Company or any Purchaser for any commission, fee or other compensation pursuant to any
agreement, arrangement or understanding entered into by or on behalf of the Purchaser. Purchaser acknowledges that it is purchasing the Securities directly from the Company and not from the Placement Agent. 

 

 25 

 (i) Independent Investment Decision. Such Purchaser has independently evaluated the
merits of its decision to purchase Securities pursuant to the Transaction Documents, and such Purchaser confirms that it has not relied on the advice of any other Purchaser’s business and/or legal counsel in making such decision. Such Purchaser
understands that nothing in this Agreement or any other materials presented by or on behalf of the Company to the Purchaser in connection with the purchase of the Securities constitutes legal, tax or investment advice. Such Purchaser has consulted
such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase of the Securities. Such Purchaser understands that the Placement Agent has acted solely as the agent of the
Company in this placement of the Securities and such Purchaser has not relied on the business or legal advice of the Placement Agent or any of its agents, counsel or Affiliates in making its investment decision hereunder, and confirms that none of
such Persons has made any representations or warranties to such Purchaser in connection with the transactions contemplated by the Transaction Documents. 

(j) Reliance on Exemptions. Such Purchaser understands that the Securities being offered and sold to it in reliance on specific
exemptions from the registration requirements of U.S. federal and state securities laws and that the Company is relying in part upon the truth and accuracy of, and such Purchaser’s compliance with, the representations, warranties, agreements,
acknowledgements and understandings of such Purchaser set forth herein in order to determine the availability of such exemptions and the eligibility of such Purchaser to acquire the Securities. 

(k) No Governmental Review. Such Purchaser understands that no U.S. federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

 (l) Residency. Such Purchaser’s residence (if an individual) or office in which its investment decision with
respect to the Securities was made (if an entity) are located at the address immediately below such Purchaser’s name on its signature page hereto. 

(m) Trading. Purchaser acknowledges that there is no trading market for the Warrants, and no such market is expected to develop.

 (n) Knowledge as to Conditions. As of the date of this Agreement, Purchaser has no reasonable basis to believe why any
regulatory approvals, consents or statements of non-objection required or otherwise a condition to the consummation by it of the transactions contemplated by this Agreement will not be obtained. 

The Company and each of the Purchasers acknowledge and agree that no party to this Agreement has made or makes any representations or
warranties with respect to the transactions contemplated hereby other than those specifically set forth in this Article III and the Transaction Documents. 
  

 26 

 ARTICLE IV. 

OTHER AGREEMENTS OF THE PARTIES 

4.1 Transfer Restrictions. 

(a) Compliance with Laws. Notwithstanding any other provision of this Article IV, each Purchaser covenants that the Securities may
be disposed of only pursuant to an effective registration statement under, and in compliance with the requirements of, the Securities Act, or pursuant to an available exemption from, or in a transaction not subject to, the registration requirements
of the Securities Act, and in compliance with any applicable state, federal or foreign securities laws. In connection with any transfer of the Securities other than (i) pursuant to an effective registration statement, (ii) to the
Company or (iii) pursuant to Rule 144 (provided that the transferor provides the Company with reasonable assurances (in the form of seller and broker representation letters) that such securities may be sold pursuant to such rule), the Company
may require the transferor thereof to provide to the Company and the Transfer Agent, at the transferor’s expense, an opinion of counsel selected by the transferor and reasonably acceptable to the Company and the Transfer Agent (it being agreed
that in-house counsel for Purchaser shall be reasonably acceptable to Company), the form and substance of which opinion shall be reasonably satisfactory to the Company and the Transfer Agent, to the effect that such transfer does not require
registration of such transferred Securities under the Securities Act. As a condition of transfer (other than pursuant to clauses (i), (ii) or (iii) of the preceding sentence), any such transferee shall agree in writing to be bound by
the terms of this Agreement and shall have the rights of a Purchaser under this Agreement with respect to such transferred Securities.

(b) Legends. Certificates evidencing the Securities shall bear any legend as required by the “blue sky” laws of any state
and a restrictive legend in substantially the following form (and, with respect to Securities held in book-entry form, the Transfer Agent will record such a legend on the share register), until such time as they are not required under
Section 4.1(c) or applicable law: 
 THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE
SECURITIES ACT OR (B) AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS AS EVIDENCED BY A LEGAL OPINION
OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS TRANSFER AGENT OR (II) UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT (PROVIDED THAT THE TRANSFEROR PROVIDES THE COMPANY WITH REASONABLE ASSURANCES (IN THE FORM OF SELLER AND BROKER
REPRESENTATION LETTERS) THAT THE SECURITIES MAY BE SOLD 
  

 27 

 
PURSUANT TO SUCH RULE). NO REPRESENTATION IS MADE BY THE ISSUER AS TO THE AVAILABILITY OF THE EXEMPTION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT FOR RESALES OF THESE SECURITIES.

 (c) Removal of Legends. The restrictive legend set forth in Section 4.1(b) above shall be removed and the Company
shall issue a certificate without such restrictive legend or any other restrictive legend to the holder of the applicable Securities upon which it is stamped or issue to such holder by electronic delivery at the applicable balance account at DTC, if
(i) such Securities are registered for resale under the Securities Act, (ii) such Securities are sold or transferred pursuant to Rule 144 (if the transferor is not an Affiliate of the Company), or (iii) such Securities are eligible
for sale under Rule 144, without the requirement for the Company to be in compliance with the current public information required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable) as to such securities and without volume or manner-of-sale
restrictions. Following the earlier of (i) the Effective Date or (ii) Rule 144 becoming available for the resale of Securities, without the requirement for the Company to be in compliance with the current public information required
under 144(c)(1) (or Rule 144(i)(2), if applicable) as to the Securities and without volume or manner-of-sale restrictions, the Company shall instruct the Transfer Agent to remove the legend from the Securities and shall cause its counsel to issue
any legend removal opinion required by the Transfer Agent. 
 Any fees (with respect to the Transfer Agent, Company counsel or
otherwise) associated with the issuance of such opinion or the removal of such legend shall be borne by the Company. If a legend is no longer required pursuant to the foregoing, the Company will no later than three (3) Trading Days
following the delivery by a Purchaser to the Company or the Transfer Agent (with notice to the Company) of a legended certificate or instrument representing such Securities (endorsed or with stock powers attached, signatures guaranteed, and
otherwise in form necessary to affect the reissuance and/or transfer) and a representation letter to the extent required by Section 4.1(a), (such third Trading Day, the “Legend Removal Date”) deliver or cause to be delivered to
such Purchaser a certificate or instrument (as the case may be) representing such Securities that is free from all restrictive legends. The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge
the restrictions on transfer set forth in this Section 4.1(c). Certificates for Securities free from all restrictive legends may be transmitted by the Transfer Agent to the Purchasers by crediting the account of the Purchaser’s prime
broker with DTC as directed by such Purchaser. 
 (d) Acknowledgement. Each Purchaser hereunder acknowledges its primary
responsibilities under the Securities Act and accordingly will not sell or otherwise transfer the Securities or any interest therein without complying with the requirements of the Securities Act. Except as otherwise provided below, while the
above-referenced registration statement remains effective, each Purchaser hereunder may sell the Securities in accordance with the plan of distribution contained in the registration statement and if it does so it will comply therewith and with the
related prospectus delivery requirements unless an exemption therefrom is available or unless the Securities are sold pursuant to Rule 144. Each Purchaser, severally and not jointly with the other Purchasers, agrees that if it is notified by
the Company in writing at any time that 
  

 28 

 
the registration statement registering the resale of the Securities is not effective or that the prospectus included in such registration statement no longer complies with the requirements of
Section 10 of the Securities Act, the Purchaser will refrain from selling such Securities until such time as the Purchaser is notified by the Company that such registration statement is effective or such prospectus is compliant with
Section 10 of the Exchange Act, unless such Purchaser is able to, and does, sell such Securities pursuant to an available exemption from the registration requirements of Section 5 of the Securities Act. 

(e) Buy-In. If the Company shall fail for any reason or for no reason to issue to a Purchaser unlegended certificates within three
(3) Trading Days of receipt of all documents necessary for the removal of the legend set forth above (the “Deadline Date”), then, in addition to all other remedies available to such Purchaser, if on or after the Trading Day
immediately following such three (3) Trading Day period, such Purchaser purchases (in an open market transaction or otherwise) Securities (or a broker or trading counterparty through which the Purchaser has agreed to sell shares makes such
purchase) to deliver in satisfaction of a sale by the holder of Securities that such Purchaser anticipated receiving from the Company without any restrictive legend (a “Buy-In”), then the Company shall, within three (3) Trading
Days after such Purchaser’s request and in such Purchaser’s sole discretion, either (i) pay cash to the Purchaser in an amount equal to such Purchaser’s total purchase price (including brokerage commissions, if any) for the
Securities so purchased (the “Buy-In Price”), at which point the Company’s obligation to deliver such certificate (and to issue such Securities) shall terminate, or (ii) promptly honor its obligation to deliver to such
Purchaser a certificate or certificates representing such Securities and pay cash to the Purchaser in an amount equal to the excess (if any) of the Buy-In Price over the product of (a) such number of Securities, times (b) the closing bid
price of such security on the Deadline Date. 
 4.2 Acknowledgment of Dilution. The Company acknowledges that the issuance
of the Securities may result in dilution of the outstanding common shares. The Company further acknowledges that its obligations under the Transaction Documents, including without limitation its obligation to issue the Securities pursuant to
the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless
of the dilutive effect that such issuance may have on the ownership of the other shareholders of the Company. 
 4.3 Furnishing
of Information. In order to enable the Purchasers to sell the Securities under Rule 144 of the Securities Act, for a period of one year from the Closing, the Company shall maintain the registration of the Common Shares under Section 12(b)
or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act. During
such one year period, if the Company is not required to file reports pursuant to such laws, it will prepare and furnish to the Purchasers and make publicly available the information described in Rule 144(c)(2), if the provision of such information
will allow resales of the Securities pursuant to Rule 144. 
  

 29 

 4.4 Form D and Blue Sky. The Company agrees to timely file a Form D with
respect to the Securities as required under Regulation D. The Company, on or before the Closing Date, shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for or to qualify the
Securities for sale to the Purchasers at the Closing pursuant to this Agreement under applicable securities or “Blue Sky” laws of the states of the United States (or to obtain an exemption from such qualification). The Company shall make
all filings and reports relating to the offer and sale of the Securities required under applicable securities or “Blue Sky” laws of the states of the United States following the Closing Date. 

4.5 No Integration. The Company shall not, and shall use its commercially reasonable efforts to ensure that no Affiliate of the
Company shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that will be integrated with the offer or sale of the Securities in a manner that
would require the registration under the Securities Act of the sale of the Securities to the Purchasers. 
 4.6 Securities Laws
Disclosure; Publicity. By 6:00 p.m., New York City time, on the Closing Date, the Company shall issue one or more press releases (collectively, the “Press Release”) reasonably acceptable to the Purchasers disclosing all
material terms of the transactions contemplated hereby. On or before 9:00 a.m., New York City time, on the fourth Trading Day immediately following the execution of this Agreement, the Company will file a Current Report on Form 8-K with the
Commission describing the terms of the Transaction Documents (and including as exhibits to such Current Report on Form 8-K the material Transaction Documents (including, without limitation, this Agreement, the Certificate of Determination, the
Warrant and the Registration Rights Agreement)). To the extent not previously disclosed by the Company, in the Company’s SEC Reports the Company shall disclose any material non-public information provided to any Purchaser (the
“Non-Public Information”). From and after the filing of the Company’s most recent SEC Report, no Purchaser shall be in possession of any material non-public information received prior to the date of this Agreement from the
Company, any Subsidiary or any of their respective officers, directors or employees, that is not disclosed in the SEC Reports. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser or any Affiliate or
investment adviser of any Purchaser, or include the name of any Purchaser or any Affiliate or investment adviser of any Purchaser in any press release or filing with the Commission (other than the Registration Statement) or any regulatory agency or
Trading Market, without the prior written consent of such Purchaser, except (i) as required by federal securities law in connection with (A) any registration statement contemplated by the Registration Rights Agreement and (B) the
filing of final Transaction Documents with the Commission and (ii) to the extent such disclosure is required by law, at the request of the staff of the Commission or Trading Market regulations, in which case the Company shall provide the
Purchasers with prior written notice of such disclosure permitted under this subclause (ii). Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement
and the Non-Public Information are publicly disclosed by the Company, such Purchaser will maintain the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction).

  

 30 

 4.7 Non-Public Information. Except with the express written consent of such Purchaser
and unless prior thereto such Purchaser shall have executed a written agreement regarding the confidentiality and use of such information, the Company shall not, and shall cause each Subsidiary and each of their respective officers, directors,
employees and agents, not to, and each Purchaser shall not directly solicit the Company, any of its Subsidiaries or any of their respective officers, directors, employees or agents to provide any Purchaser with any material, non-public information
regarding the Company or any of its Subsidiaries from and after the filing of the Press Release. 
 4.8 Indemnification.

 (a) Indemnification of Purchasers. In addition to the indemnity provided in the Registration Rights Agreement, the
Company will indemnify and hold each Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of
such title or any other title), each Person who controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or
employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling person (each, a “Purchaser Party”) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation that any such Purchaser
Party may suffer or incur as a result of (i) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents or (ii) any action instituted against a
Purchaser Party in any capacity, or any of them or their respective affiliates, by any shareholder of the Company who is not an affiliate of such Purchaser Party, with respect to any of the transactions contemplated by this Agreement. The
Company will not be liable to any Purchaser Party under this Agreement to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party’s breach of any of the representations, warranties,
covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. 
 (b) Conduct of
Indemnification Proceedings. Promptly after receipt by any Person (the “Indemnified Person”) of notice of any demand, claim or circumstances which would or might give rise to a claim or the commencement of any action,
proceeding or investigation in respect of which indemnity may be sought pursuant to Section 4.8(a), such Indemnified Person shall promptly notify the Company in writing and the Company shall assume the defense thereof, including the employment
of counsel reasonably satisfactory to such Indemnified Person, and shall assume the payment of all fees and expenses; provided, however, that the failure of any Indemnified Person so to notify the Company shall not relieve the Company of its
obligations hereunder except to the extent that the Company is actually and materially and adversely 
  

 31 

 
prejudiced by such failure to notify. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the
expense of such Indemnified Person unless: (i) the Company and the Indemnified Person shall have mutually agreed to the retention of such counsel; (ii) the Company shall have failed promptly to assume the defense of such proceeding and to
employ counsel reasonably satisfactory to such Indemnified Person in such proceeding; or (iii) in the reasonable judgment of counsel to such Indemnified Person, representation of both parties by the same counsel would be inappropriate due to
actual or potential differing interests between them. The Company shall not be liable for any settlement of any proceeding effected without its written consent, which consent shall not be unreasonably withheld, delayed or conditioned. Without the
prior written consent of the Indemnified Person, which consent shall not be unreasonably withheld, delayed or conditioned, the Company shall not effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person
is or could have been a party and indemnity could have been sought hereunder by such Indemnified Party, unless such settlement includes an unconditional release of such Indemnified Person from all liability arising out of such proceeding.

 4.9 Listing of Common Shares. The Company will use its reasonable best efforts to list the Underlying Shares for
quotation on the NASDAQ Global Market and maintain the listing of the Common Shares on the NASDAQ Global Market. 
 4.10 Use of
Proceeds. Except for $17 million of the net proceeds which will be retained by the Company, the remaining net proceeds of the capital raised through the transactions contemplated by this Agreement shall be contributed to PBI Bank in the form of
a cash contribution or purchase of additional common equity. 
 4.11 Shareholders Meeting. The Company shall call a meeting of
its shareholders, as promptly as practicable following the Closing, but in no event shall the meeting be later than December 30, 2010, to vote on a proposal (the “Shareholder Proposal”) to approve (i) the conversion of the
Preferred Shares and the Non-Voting Preferred Shares into Common Stock for purposes of Rule 5635 of the NASDAQ Stock Market Rules, and (ii) authorizing a new class of Non-Voting Common Stock to allow for the exercise of the Warrants (such
approval of the Shareholder Proposal, “Shareholder Approvals”). The Board of Directors of the Company shall recommend to the Company’s shareholders that such shareholders vote in favor of the Shareholder Proposal. In connection
with such meeting, the Company shall promptly prepare and file (but in no event more than thirty (30) days after the Closing Date) with the Commission a preliminary proxy statement, shall use its reasonable best efforts to respond to any
comments of the Commission or its staff and to cause a definitive proxy statement related to such shareholders’ meeting to be mailed to the Company’s shareholders not more than fifteen (15) business days after clearance thereof by the
Commission, and shall use its reasonable best efforts to solicit proxies for such Shareholder Approval. The Company shall notify each Purchaser promptly of the receipt of any comments from the SEC or its staff with respect to the proxy statement and
of any request by the SEC or its staff for amendments or supplements to such proxy statement or for additional information (but the Company shall not provide any Purchaser with any material, nonpublic information, unless requested by such Purchaser
and pursuant to a 
  

 32 

 
written agreement regarding the confidentiality and use of such information). If at any time prior to such shareholders’ meeting there shall occur any event that is required to be set forth
in an amendment or supplement to the proxy statement, the Company shall as promptly as practicable prepare and mail to its shareholders such an amendment or supplement. In the event that Shareholder Approval is not obtained at such shareholder
meeting, the Company shall include a proposal to approve (and the Board of Directors shall recommend approval of) such proposal at a meeting of its shareholders to be held no less than once in each subsequent six-month period beginning on the date
of such shareholder meeting until such approval is obtained. 
 4.12 Reservation of Underlying Shares. The Company will reserve
an appropriate number of its shares for issuance as Underlying Shares. 
 4.13 Limitation on Beneficial Ownership. Except
as provided herein, no Purchaser (and its Affiliates or any other Persons with which it is acting in concert or whose holdings would otherwise be required to be aggregated for purposes of the BHC Act or the Change in Bank Control Act) will be
entitled to purchase a number of common shares that would result in such Purchaser becoming, directly or indirectly, the beneficial owner (as determined under Rule 13d-3 under the Exchange Act) of more than 9.9% of the number of voting common shares
issued and outstanding (based on the number of outstanding shares as of the Closing Date). 
 4.14 No Change of
Control. The Company shall use reasonable best efforts to obtain all necessary irrevocable waivers, adopt any required amendments and make all appropriate determinations so that the issuance of the Securities to the Purchasers will not trigger
a “change of control” or other similar provision in any of the agreements to which the Company or any of its Subsidiaries is a party, including without limitation any employment, “change in control,” severance or other agreements
and any benefit plan, which results in payments to the counterparty or the acceleration of vesting of benefits. 
 4.15 Gross-Up
Rights. 
 (a) Sale of New Securities. For so long as a Purchaser, together with its Affiliates, owns 4.9% or more of all of the
outstanding shares of Common Stock (counting for such purposes all shares of Common Stock into or for which any securities owned by the Purchaser are directly or indirectly convertible or exercisable and, for the avoidance of doubt, including as
shares owned and outstanding all shares of Common Stock issued by the Company after the Closing) (before giving effect to any issuances triggering provisions of this Section), if at any time after the date hereof the Company makes any public or
nonpublic offering or sale of Common Stock, or securities convertible into Common Stock (any such security, a “New Security”) (other than (i) any Common Stock or other securities issuable upon the exercise or conversion of any
securities of the Company issued or agreed or contemplated to be issued as of the date hereof; (ii) pursuant to the granting or exercise of employee stock options or other stock incentives pursuant to the Company’s stock incentive plans
approved by the Board of Directors or the issuance of stock pursuant to the Company’s employee stock purchase plan approved by the Board of Directors or similar plan where stock is being issued or offered to a trust, other entity or otherwise,
for the benefit of any employees, officers or directors of the Company, in 
  

 33 

 
each case in the ordinary course of providing incentive compensation; or (iii) issuances of capital stock as full or partial consideration for a merger, acquisition, joint venture, strategic
alliance, license agreement or other similar nonfinancing transaction approved by the Board), then the Purchaser shall be afforded the opportunity to acquire from the Company for the same price (net of any underwriting discounts or sales
commissions) and on the same terms as such securities are proposed to be offered to others, up to the amount of New Securities in the aggregate required to enable it to maintain its proportionate Common Stock-equivalent interest in the Company
immediately prior to any such issuance of New Securities. The amount of New Securities that the Purchaser shall be entitled to purchase in the aggregate shall be determined by multiplying (x) the total number or principal amount of such offered
New Securities by (y) a fraction, the numerator of which is the sum of (i) the number of shares of Common Stock held by the Purchaser, if any, and (ii) the number of shares of Common Stock represented by the Preferred Shares and the
Non-Voting Preferred Shares held by the Purchaser on an as-converted basis as of such date, if any, and the denominator of which is the sum of (i) the number of shares of Common Stock then outstanding, (ii) the number of shares of Common
Stock represented by the Preferred Shares and the Non-Voting Preferred Shares on an as-converted basis as of such date. Notwithstanding anything herein to the contrary, in no event shall the Purchaser have the right to purchase securities hereunder
to the extent such purchase would result in such Purchaser, together with its Affiliates, owning a greater percentage interest in the Company than such Purchaser held immediately prior to the issuance of the New Securities (counting for such
purposes all shares of Common Stock into or for which any securities owned by the Purchaser are directly or indirectly convertible or exercisable). 

(b) Notice. In the event the Company proposes to offer or sell New Securities (the “Offering”), it shall give the
Purchaser written notice of its intention, describing the price (or range of prices), anticipated amount of securities, timing, and other terms upon which the Company proposes to offer the same (including, in the case of a registered public offering
and to the extent possible, a copy of the prospectus included in the registration statement filed with respect to such offering), no later than ten Business Days, as the case may be, after the initial filing of a registration statement with the SEC
with respect to an underwritten public offering, after the commencement of marketing with respect to a Rule 144A offering or after the Company proposes to pursue any other offering. If the information contained in the notice constitutes material
non-public information (as defined under the applicable securities laws), the Company shall deliver such notice only to the individuals identified on the Purchaser’s signature page hereto, and shall not communicate the information to anyone
else acting on behalf of the Purchaser without the consent of one of the designated individuals. The Purchaser shall have ten Business Days from the date of receipt of such a notice to notify the Company in writing that it intends to exercise its
rights provided in this Section 4.15 and as to the amount of New Securities the Purchaser desires to purchase, up to the maximum amount calculated pursuant to Section 4.15(a). Such notice shall constitute a nonbinding indication of
interest of the Purchaser to purchase the amount of New Securities so specified at the price and other terms set forth in the Company’s notice to it. The failure of the Purchaser to respond within such ten Business Day period shall be deemed to
be a waiver of such Purchaser’s rights under this Section 4.15 only with respect to the Offering described in the applicable notice. 
  

 34 

 (c) Purchase Mechanism. If the Purchaser exercises its rights provided in this
Section 4.15, the closing of the purchase of the New Securities in connection with the closing of the Offering with respect to which such right has been exercised shall take place within 30 calendar days after the giving of notice of such
exercise, which period of time shall be extended for a maximum of 180 days in order to comply with applicable laws and regulations (including receipt of any applicable regulatory or stockholder approvals). Notwithstanding anything to the contrary
herein, the closing of the purchase of the New Securities by the Purchasers will occur no earlier than the closing of the Offering triggering the right being exercised by the Purchaser. Each of the Company and the Purchaser agrees to use its
commercially reasonable efforts to secure any regulatory or stockholder approvals or other consents, and to comply with any law or regulation necessary in connection with the offer, sale and purchase of, such New Securities. 

(d) Failure of Purchase. In the event the Purchaser fails to exercise its rights provided in this Section 4.15 within said 10
Business Day period or, if so exercised, the Purchaser is unable to consummate such purchase within the time period specified in Section 4.15(c) above because of its failure to obtain any required regulatory or stockholder consent or approval,
the Company shall thereafter be entitled (during the period of 60 days following the conclusion of the applicable period) to sell or enter into an agreement (pursuant to which the sale of the New Securities covered thereby shall be consummated, if
at all, within 90 days from the date of said agreement) to sell the New Securities not elected to be purchased pursuant to this Section 4.15 by the Purchaser or which the Purchaser is unable to purchase because of such failure to obtain any
such consent or approval, at a price and upon terms no more favorable in the aggregate to the purchasers of such securities than were specified in the Company’s notice to the Purchaser. Notwithstanding the foregoing, if such sale is subject to
the receipt of any regulatory or stockholder approval or consent or the expiration of any waiting period, the time period during which such sale may be consummated shall be extended until the expiration of five Business Days after all such approvals
or consents have been obtained or waiting periods expired, but in no event shall such time period exceed 180 days from the date of the applicable agreement with respect to such sale. In the event the Company has not sold the New Securities or
entered into an agreement to sell the New Securities within said 60-day period (or sold and issued New Securities in accordance with the foregoing within 90 days from the date of said agreement (as such period may be extended in the manner described
above for a period not to exceed 180 days from the date of said agreement)), the Company shall not thereafter offer, issue or sell such New Securities without first offering such securities to the Purchaser in the manner provided above. 

(e) Non-Cash Consideration. In the case of the offering of securities for a consideration in whole or in part other than cash, including
securities acquired in exchange therefor (other than securities by their terms so exchangeable), the consideration other than cash shall be deemed to be the fair value thereof as determined by the Board of Directors; provided, however, that such
fair value as determined by the Board of Directors shall not exceed the aggregate market price of the securities being offered as of the date the Board of Directors authorizes the offering of such securities. 

(f) Termination. Purchaser’s rights hereunder shall expire on the earlier of the following: (i) three years from the Closing;
or (ii) at such time that the Purchaser, together 
  

 35 

 
with its Affiliates, owns less than 4.9% of all of the outstanding shares of Common Stock (counting for such purposes all shares of Common Stock into or for which any securities owned by the
Purchaser are directly or indirectly convertible or exercisable and, for the avoidance of doubt, including as shares owned and outstanding all Common Shares issued by the Company after the Closing) (before giving effect to any issuances triggering
provisions of Section 4.15). 
 (g) Cooperation. The Company and the Purchaser shall cooperate in good faith to facilitate
the exercise of the Purchaser’s rights under this Section 4.15, including to secure any required approvals or consents. 

(h) No Assignment of Rights. The rights of a Purchaser described in this Section 4.15 shall be personal to Purchaser and the
transfer, assignment and/or conveyance of said rights from Purchaser to any other person and/or entity is prohibited and shall be void and of no force or effect. 

4.16 No Additional Issuances. Between the date of this Agreement and the Closing Date, except for the issuance of common shares
issuable as of the date hereof as set forth in Schedule 3.1(g) and the Securities being issued pursuant to this Agreement, the Company shall not issue or agree to issue any additional common shares or other securities which provide the holder
thereof the right to convert such securities into common shares. 
 4.17 No Rights Agreement. The Company shall not enter
into any poison pill agreement, shareholders’ rights plan or similar agreement that shall limit the rights of a Purchaser to acquire common shares unless such poison pill agreement, shareholders’ rights plan or similar agreement grants an
exemption or waiver to the Purchaser immediately effective upon execution of such plan or agreement that would allow the Purchaser to acquire such Common Shares. 

4.18 Certain Transactions. The Company will not merge or consolidate into, or sell, transfer or lease all or substantially all of
its property or assets to, any other party unless the successor, transferee or lessee party, as the case may be (if not the Company), expressly assumes the due and punctual performance and observance of each and every covenant and condition of this
Agreement to be performed and observed by the Company. 
 4.19 Board/Observer Rights. 

(a) The Company covenants and agrees that no later than Closing, to be effective as of the Closing, the Board of Directors shall cause
one person nominated by Patriot Financial Partners, L.P. or its assignee or any other Purchaser who purchases $10 million or more of Securities (the “Lead Purchaser”) to be elected or appointed to the Board of Directors (such
designee or any successor designee of the Lead Purchaser, the “Designated Board Member”), subject to satisfaction of the legal and governance requirements regarding service as a director of the Company and to the reasonable approval
of the Nominating and Governance Committee of the Board of Directors (such approval not to be unreasonably withheld or delayed). 
  

 36 

 (b) After such appointment or election of the Designated Board Member, so long as the Lead
Purchaser holds, in the aggregate, four point nine percent (4.9%) or more of the voting Common Stock, then the Company will be required to recommend to its shareholders the election of the Designated Board Member at the Company’s annual
meeting, subject to satisfaction of the legal and governance requirements regarding service as a director of the Company and to the reasonable approval of the Nominating and Governance Committee of the Board of Directors (such approval not to be
unreasonably withheld or delayed). The Company shall use its best efforts to have the Designated Board Member elected as a director of the Company and the Company shall solicit proxies for each such person to the same extent as it does for any of
its other nominees to the Board of Directors. If the Lead Purchaser no longer owns the minimum number of shares of voting Common Stock specified in the prior sentence, the Lead Purchaser will have no further rights under this Section 4.19, and,
at the written request of the Board of Directors, shall use its best efforts to cause its Designated Board Member to resign from the Board of Directors as promptly as possible thereafter. 

(c) For only so long as the Lead Purchaser has the right to nominate the Designated Board Member pursuant to Section 4.19, the Lead
Purchaser shall have the power to designate the Designated Board Member’s replacement upon the death, resignation, retirement, disqualification or removal from office of such director, or to remove and replace such Designated Board Member at
any time. The Board of Directors will use its best efforts to take all action required to fill the vacancy resulting therefrom with such person (including such person, subject to applicable law, being the Company’s and the Nominating and
Governance Committee’s nominee to serve on the Board of Directors, using its best efforts to have such person elected as director of the Company and the Company soliciting proxies for such person to the same extent as it does for any of its
other nominees to the Board of Directors). 
 (d) For only so long as the Lead Purchaser has the right to nominate the
Designated Board Member pursuant to Section 4.19, in lieu of appointing a director, the Lead Purchaser shall be entitled to send not more than one (1) representative to attend and participate in all Board and Board committee meetings as an
“Board Observer” (but not to vote on any matters thereat). 
 (e) The Board Observer shall be entitled to notice of
all Board and Board committee meetings and distributions of all Board and Board committee materials in the same manner and at the same time as such notices and materials are provided to Board and Board committee members, and if the Board (or Board
committee) proposes to take action by written consent in lieu of a meeting, the Board Observer shall receive written notice thereof and shall also receive written notice prior to the effective date of the applicable consent with respect to such
action, describing in reasonable detail the nature and substance of such action; provided, however, that (A) the Board Observer may be excluded from executive sessions comprised solely of independent directors by the lead or presiding
independent director if, in his good faith judgment, such exclusion is to facilitate candid discussion of particularly sensitive matters (it being understood that it is not expected that the Board Observer would be excluded from routine executive
sessions), (B) the Company or the Board of Directors shall have the right to withhold any information and to exclude the Board Observer from any meeting or portion thereof (1) if 

 

 37 

 
doing so is, in the reasonable good faith judgment of the Company, after consultation with counsel, advisable or necessary to protect the attorney-client privilege between the Company and counsel
or (2) if the Board of Directors reasonably determines in good faith, after consultation with counsel, that attendance by the Board Observer would conflict with fiduciary requirements under applicable law and (C) the Lead Purchaser shall
cause its Board Observer to agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information provided to such Board Observer. The Lead Purchaser covenants and agrees to hold all such information obtained from
its Board Observer as provided in the prior sentence in confidence pursuant to the Non-Disclosure Agreement entered into between the Company and Patriot dated March 24, 2010. For purposes hereof, the notice, right to materials and the rights
set forth herein shall include each board and board committee of each of the Subsidiaries of the Company. 
 (f) For so long as
the Lead Purchaser holds, in the aggregate, four point nine percent (4.9%) or more of the voting Common Stock, the Lead Purchaser shall be entitled to notice of all Board and Board committee meetings and distributions of all Board and Board
committee materials in the same manner and at the same time as such notices and materials are provided to Board and Board committee members; provided, however, that the Company or the Board of Directors shall have the right to withhold any
information and to exclude the Board Observer from any meeting or portion thereof (A) if doing so is, in the reasonable good faith judgment of the Company, after consultation with counsel, advisable or necessary to protect the attorney-client
privilege between the Company and counsel or (B) if the Board of Directors reasonably determines in good faith, after consultation with counsel, that attendance by the Board Observer would conflict with fiduciary requirements under applicable
law. The Lead Purchaser covenants and agrees to hold all such information obtained from the Company as provided in the prior sentence in confidence pursuant to the Non-Disclosure Agreement entered into between the Company and the Lead Purchaser
dated March 24, 2010. For purposes hereof, the notice, right to materials and the rights set forth herein shall include each board and board committee of each of the Subsidiaries of the Company. 

(g) The Designated Board Member and the Board Observer shall be reimbursed for reasonable out-of-pocket expenses incurred by them in
connection with their attendance at any meeting, to the same extent that the members of the Board (or board committee) are entitled to such reimbursement. 

(h) So long as the Lead Purchaser has the right to appoint a Designated Board Member pursuant to this Section 4.19, the Lead
Purchaser shall have the right to either nominate one person (the “Bank Board Representative”) to be elected or appointed as director to the board of directors of the Bank (the “Bank Board”) or to appoint one person
to attend all meetings of the Bank Board and all committees thereof as an observer (the “Bank Board Observer”); provided that the appointment by the Lead Purchaser of a Bank Board Observer shall not prevent the Lead Purchaser from
nominating a Bank Board Representative in lieu of a Bank Board Observer at a future time. The obligations of the Company otherwise with respect to, and the conditions on the appointment and, if applicable, directorship of, the Bank Board
Representative and the Bank Board Observer shall be substantially the same as those with respect to or applicable to the Designated Board Member and Board Observer, respectively. 

 

 38 

 (i) The rights provided by this Section 4.19 are personal to the Lead Purchaser and in
no event shall such rights be assignable. 
 4.20 Dividends. After Closing, the Company agrees to reduce the cash dividend on
its Common Shares to no more than $0.40 per annum ($0.10 per quarter) and establish a payout ratio guidance policy of 35% of after-tax earnings on an on-going basis, subject to the applicable regulations and policies of the bank regulatory agencies.

 ARTICLE V. 

CONDITIONS PRECEDENT TO CLOSING 

5.1 Conditions Precedent to the Obligations of the Purchasers to Purchase Securities. The obligation of each Purchaser to acquire
Securities at the Closing is subject to the fulfillment to such Purchaser’s satisfaction, on or prior to the Closing Date, of each of the following conditions, any of which may be waived by such Purchaser (as to itself only): 

(a) Representations and Warranties. The representations and warranties of the Company contained herein shall be true and correct as
of the date when made and as of the Closing Date, as though made on and as of such date, except for such representations and warranties that speak as of a specific date. 

(b) Performance. The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements
and conditions required by the Transaction Documents to be performed, satisfied or complied with by it at or prior to the Closing. 

(c) No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by the Transaction Documents. 

(d) Consents. The Company shall have obtained in a timely fashion any and all consents, permits, approvals, registrations and
waivers necessary for consummation of the purchase and sale of the Securities (including all Required Approvals), all of which shall be and remain so long as necessary in full force and effect. 

(e) No Suspensions of Trading in Common Shares; Listing. The Common Shares (i) shall be designated for quotation or listed on
the Principal Trading Market and (ii) shall not have been suspended, as of the Closing Date, by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal
Trading Market have been threatened, as of the Closing Date, either (A) in writing by the Commission or the Principal Trading Market or (B) by falling below the minimum listing maintenance requirements of the Principal Trading
Market. The Company shall have obtained approval of the Principal Trading Market to list the Underlying Shares. 
  

 39 

 (f) Company Deliverables. The Company shall have delivered the Company Deliverables in
accordance with Section 2.2(a). 
 (g) Compliance Certificate. The Company shall have delivered to each Purchaser a
certificate, dated as of the Closing Date and signed by its Chief Executive Officer or its Chief Financial Officer, dated as of the Closing Date, certifying to the fulfillment of the conditions specified in Sections 5.1(a) and (b). 

(h) Minimum Gross Proceeds. The Company shall simultaneously issue and deliver at such Closing to the Purchasers hereunder in the
aggregate at least a sufficient number of Common Shares and Warrants against payment of an aggregate Purchase Price of at least $26 million. 

(i) Termination. This Agreement shall not have been terminated as to such Purchaser in accordance with Section 6.16 herein.

 (j) Certificate of Determination. The Company shall have filed the Certificate of Determination with the Kentucky Secretary.

 (k) J. Chester Porter and Maria L. Bouvette shall have executed the Voting and Support Agreement in the form attached hereto
as Exhibit “H”. 
 5.2 Conditions Precedent to the Obligations of the Company to sell Securities. The
Company’s obligation to sell and issue the Securities at the Closing is subject to the fulfillment to the satisfaction of the Company on or prior to the Closing Date of the following conditions, any of which may be waived by the Company:

 (a) Representations and Warranties. The representations and warranties made by the Purchaser in Section 3.2 hereof
shall be true and correct as of the date when made, and as of the Closing Date as though made on and as of such date, except for representations and warranties that speak as of a specific date. 

(b) Performance. Such Purchaser shall have performed, satisfied and complied in all material respects with all covenants, agreements
and conditions required by the Transaction Documents to be performed, satisfied or complied with by such Purchaser at or prior to the Closing Date. 

(c) No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by the Transaction Documents. 

(d) Consents. The Company shall have obtained in a timely fashion any and all consents, permits, approvals, registrations and
waivers necessary for consummation of the purchase and sale of the Securities, all of which shall be and remain so long as necessary in full force and effect including, without limitations, all waivers and consents set forth or referred to in
Sections 3.1(vv) and 4.13 hereof. 
  

 40 

 (e) Purchasers Deliverables. Such Purchaser shall have delivered its Purchaser
Deliverables in accordance with Section 2.2(b). 
 (f) Termination. This Agreement shall not have been terminated as
to such Purchaser in accordance with Section 6.16 herein. 
 ARTICLE VI. 

MISCELLANEOUS 

6.1 Fees and Expenses. The parties hereto shall be responsible for the payment of all expenses incurred by them in connection with
the preparation and negotiation of the Transaction Documents and the consummation of the transactions contemplated hereby, except that the Company shall reimburse Patriot $50,000 for its expenses associated with the transactions contemplated by this
Agreement if and when Closing occurs. The Company shall pay all amounts owed to the Placement Agent relating to or arising out of the transactions contemplated hereby. The Company shall pay all Transfer Agent fees, stamp taxes and other
taxes and duties levied in connection with the sale and issuance of the Securities to the Purchasers. 
 6.2 Entire
Agreement. The Transaction Documents, together with the Exhibits and Schedules thereto, contain the entire understanding of the parties with respect to the subject matter hereof and supersede all prior agreements, understandings, discussions
and representations, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules. At or after the Closing, and without further consideration, the Company and the
Purchasers will execute and deliver to the other such further documents as may be reasonably requested in order to give practical effect to the intention of the parties under the Transaction Documents. 

6.3 Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via facsimile (provided the sender receives a machine-generated confirmation of successful
transmission) at the facsimile number specified in this Section prior to 5:00 p.m., New York City time, on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the
facsimile number specified in this Section on a day that is not a Trading Day or later than 5:00 p.m., New York City time, on any Trading Day, (c) the Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight
courier service with next day delivery specified, or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as follows: 

 

					
	If to the Company:	  	 Porter Bancorp, Inc.

		  	 2500 Eastpoint Parkway

		  	 Louisville, Kentucky 40223

		  	 Attention: Maria L. Bouvette, Chief Executive Officer

		  	 Cc: C. Bradford Harris, Corporate General Counsel

		  	 Telephone: (502) 499-4800

		  	 Fax:

  

 41 

					
		
	With a copy to:	  	 Frost Brown Todd LLC

		  	 400 W. Market Street

Louisville, Kentucky 93401

		  
		  	Attention:	  	R. James Straus
		  		  	Alan K. MacDonald
		  	 Telephone: (502) 589-5400

		  	 Fax: (502) 581-1087

		
	If to Purchaser:	  	 At the address set forth on the signature page hereto.

or such other address as may be designated in writing hereafter, in the same manner, by such Person. 

6.4 Amendments; Waivers; No Additional Consideration. No provision of this Agreement may be waived or amended except in a written
instrument signed, in the case of an amendment, by the Company and each of the Purchasers affected by such amendment or, in the case of a waiver, by the party against whom enforcement of any such waiver is sought. No waiver of any default with
respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any
delay or omission of either party to exercise any right hereunder in any manner impair the exercise of any such right. No consideration shall be offered or paid to any Purchaser to amend or consent to a waiver or modification of any provision of any
Transaction Document unless the same consideration is also offered to all Purchasers who then hold Securities. 
 6.5
Construction. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the
language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. This Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall
arise favoring or disfavoring any party by virtue of the authorship of any provisions of this Agreement or any of the Transaction Documents. 

6.6 Successors and Assigns. The provisions of this Agreement shall inure to the benefit of and be binding upon the parties and their
successors and permitted assigns. This Agreement, or any rights or obligations hereunder, may not be assigned by the Company without 

 

 42 

 
the prior written consent of the Purchasers. Except as specifically provided otherwise in this Agreement, any Purchaser may assign its rights hereunder in whole or in part to any Person to whom
such Purchaser assigns or transfers any Securities in compliance with the Transaction Documents and applicable law, provided such transferee shall agree in writing to be bound, with respect to the transferred Securities, by the terms and conditions
of this Agreement that apply to the “Purchasers”. 
 6.7 No Third-Party Beneficiaries. This Agreement is intended
for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, other than Indemnified Persons and (with respect to
Section 3.2(g) only) the Placement Agent. 
 6.8 Governing Law. All questions concerning the construction, validity,
enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the Commonwealth of Kentucky, without regard to the principles of conflicts of law thereof. Each party agrees
that all Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective Affiliates, employees or
agents) may be commenced on a non-exclusive basis in the Kentucky Courts. Each party hereto hereby irrevocably submits to the non-exclusive jurisdiction of the Kentucky Courts for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim that it is not
personally subject to the jurisdiction of any such Kentucky Court, or that such Proceeding has been commenced in an improper or inconvenient forum. Each party hereto hereby irrevocably waives personal service of process and consents to process being
served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO
THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. 

6.9 Survival. Subject to applicable statute of limitations, the representations, warranties, agreements and covenants contained
herein shall survive the Closing and the delivery of the Securities. 
 6.10 Execution. This Agreement may be executed in
two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both
parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission, or by e-mail delivery of a “.pdf” format data 

 

 43 

 
file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile
signature page were an original thereof. 
 6.11 Severability. If any provision of this Agreement is held to be invalid or
unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision
that is a reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Agreement. 

6.12 Replacement of Shares. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the
Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the
Company and the Transfer Agent of such loss, theft or destruction and the execution by the holder thereof of a customary lost certificate affidavit of that fact and an agreement to indemnify and hold harmless the Company and the Transfer Agent for
any losses in connection therewith or, if required by the Transfer Agent, a bond in such form and amount as is required by the Transfer Agent. The applicants for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs associated with the issuance of such replacement Shares. If a replacement certificate or instrument evidencing any Securities is requested due to a mutilation thereof, the Company may require delivery of such mutilated certificate
or instrument as a condition precedent to any issuance of a replacement. 
 6.13 Remedies. In addition to being entitled to
exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be
adequate compensation for any loss incurred by reason of any breach of obligations described in the foregoing sentence and hereby agree to waive in any action for specific performance of any such obligation (other than in connection with any action
for a temporary restraining order) the defense that a remedy at law would be adequate. 
 6.14 Payment Set Aside. To the
extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any
part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other person under
any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be
revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred. 

6.15 Independent Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any Transaction Document
are several and not joint with the obligations of 
  

 44 

 
any other Purchaser, and no Purchaser shall be responsible in any way for the performance of the obligations of any other Purchaser under any Transaction Document. The decision of each
Purchaser to purchase Securities pursuant to the Transaction Documents has been made by such Purchaser independently of any other Purchaser and independently of any information, materials, statements or opinions as to the business, affairs,
operations, assets, properties, liabilities, results of operations, condition (financial or otherwise) or prospects of the Company or any Subsidiary which may have been made or given by any other Purchaser or by any agent or employee of any other
Purchaser, and no Purchaser and any of its agents or employees shall have any liability to any other Purchaser (or any other Person) relating to or arising from any such information, materials, statement or opinions. Nothing contained herein or
in any Transaction Document, and no action taken by any Purchaser pursuant thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the
Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser acknowledges that no other Purchaser has acted as agent for such Purchaser
in connection with making its investment hereunder and that no Purchaser will be acting as agent of such Purchaser in connection with monitoring its investment in the Securities or enforcing its rights under the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights, including without limitation the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be
joined as an additional party in any proceeding for such purpose. 
 6.16 Termination. This Agreement may be terminated and
the sale and purchase of the Securities abandoned at any time prior to the Closing by either the Company or any Purchaser (with respect to itself only) upon written notice to the other, if the Closing has not been consummated on or prior to 5:00
p.m., New York City time, on the Outside Date; provided, however, that the right to terminate this Agreement under this Section 6.16 shall not be available to any Person whose failure to comply with its obligations under this Agreement
has been the cause of or resulted in the failure of the Closing to occur on or before such time. The Company shall give prompt notice of any such termination to each other Purchaser, and, if necessary, work in good faith to restructure the
transaction to allow each Purchaser that does not exercise a termination right to purchase the full number of securities set forth below such Purchaser’s name on the signature page of this Agreement while remaining in compliance with
Section 4.13. Nothing in this Section 6.16 shall be deemed to release any party from any liability for any breach by such party of the terms and provisions of this Agreement or the other Transaction Documents or to impair the right of
any party to compel specific performance by any other party of its obligations under this Agreement or the other Transaction Documents. In the event of a termination pursuant to this Section, the Company shall promptly notify all non-terminating
Purchasers. Upon a termination in accordance with this Section, the Company and the terminating Purchaser(s) shall not have any further obligation or liability (including arising from such termination) to the other, and no Purchaser will have any
liability to any other Purchaser under the Transaction Documents as a result therefrom. 
  

 45 

 6.17 Rescission and Withdrawal Right. Notwithstanding anything to the contrary
contained in (and without limiting any similar provisions of) the Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related
obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice
to its future actions and rights. 
 6.18 Adjustments in Stock Numbers and Prices. In the event of any stock split,
subdivision, dividend or distribution payable in Common Shares (or other securities or rights convertible into, or entitling the holder thereof to receive directly or indirectly Common Shares), combination or other similar recapitalization or event
occurring after the date hereof and prior to Closing, each reference in any Transaction Document to a number of shares or a price per share shall be deemed to be amended to appropriately account for such event. 

 

 46 

 IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be
duly executed by their respective authorized signatories as of the date first indicated above. 
  

			
	 PORTER BANCORP, INC.

	
	 /s/ Maria L. Bouvette

	By: Maria L. Bouvette
	 Its: President and CEO

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

[SIGNATURE PAGES FOR PURCHASERS FOLLOW] 
  

 47 

			
	NAME OF PURCHASER:	  	PATRIOT FINANCIAL PARTNERS, L.P.

  

			
	 Authorized Signatory of Purchaser

	By:	 	  

	Its:	 	  

 

					
	Aggregate Purchase Price (Subscription Amount):	  	$14,069,537	  	 
	  
 Number of Common Shares
to be Acquired:
	  	718,572	  
	 Number of Preferred Shares to be Acquired:
	  	193,563	  
	 Number of Non-Voting Preferred Shares to be Acquired:
	  	311,303	  
	 Number of Underlying Shares on the Warrant:
	  	611,720	  

  

					
	 Tax ID No.:
	  	  

	 Address for Notice:
	  	  

		  	  

		
	 Attention:
	  	  

	 Telephone No.:
	  	  

	 Fax No.:
	  	  

	 E-mail Address:
	  	  

 

							
	Delivery Instructions, if different from above:	 		 	
				
		 		 		 	c/o                             
                    
				
		 		 		 	Street:                            
               
				
		 		 		 	City/State/Zip:                           
  
				
		 		 		 	Attention:                            
         
				
		 		 		 	Telephone
No.:                             

 

 48 

			
	NAME OF PURCHASER:	  	PATRIOT FINANCIAL PARTNERS PARALLEL, L.P.

  

			
	 Authorized Signatory of Purchaser

	By:	 	  

	Its:	 	  

 

					
	Aggregate Purchase Price (Subscription Amount):	  	$2,430,467.50	  	 
	  
 Number of Common Shares
to be Acquired:
	  	124,131	  
	 Number of Preferred Shares to be Acquired:
	  	33,437	  
	 Number of Non-Voting Preferred Shares to be Acquired:
	  	53,777	  
	 Number of Underlying Shares on the Warrant:
	  	105,673	  

  

					
	 Tax ID No.:
	  	  

	 Address for Notice:
	  	  

		  	  

		
	 Attention:
	  	  

	 Telephone No.:
	  	  

	 Fax No.:
	  	  

	 E-mail Address:
	  	  

 

							
	Delivery Instructions, if different from above:	 		 	
				
		 		 		 	c/o                             
                    
				
		 		 		 	Street:                            
               
				
		 		 		 	City/State/Zip:                           
  
				
		 		 		 	Attention:                            
         
				
		 		 		 	Telephone
No.:                             

 

 49 

			
	NAME OF PURCHASER:	  	 BURNHAM FINANCIAL INDUSTRIES FUND

 

			
	 Authorized Signatory of Purchaser

	By:	 	  

	Its:	 	  

 

					
	Aggregate Purchase Price (Subscription Amount):	  	 $3,000,005
	  	 
	  
 Number of Common Shares
to be Acquired:
	  	260,870
	  
	 Number of Preferred Shares to be Acquired:
	  	0
	  
	 Number of Non-Voting Preferred Shares to be Acquired:
	  	0
	  
	 Number of Underlying Shares on the Warrant:
	  	130,435
	  

  

					
	 Tax ID No.:
	  	  

	 Address for Notice:
	  	  

		  	  

		
	 Attention:
	  	  

	 Telephone No.:
	  	  

	 Fax No.:
	  	  

	 E-mail Address:
	  	  

 

							
	Delivery Instructions, if different from above:	 		 	
				
		 		 		 	c/o                             
                    
				
		 		 		 	Street:                            
               
				
		 		 		 	City/State/Zip:                           
  
				
		 		 		 	Attention:                            
         
				
		 		 		 	Telephone
No.:                             

 

 50 

			
	NAME OF PURCHASER:	  	 BURNHAM FINANCIAL SERVICES FUND

 

			
	 Authorized Signatory of Purchaser

	By:	 	  

	Its:	 	  

 

					
	Aggregate Purchase Price (Subscription Amount):	  	 $999,994
	  	 
	  
 Number of Common Shares
to be Acquired:
	  	86,956
	  
	 Number of Preferred Shares to be Acquired:
	  	0
	  
	 Number of Non-Voting Preferred Shares to be Acquired:
	  	0
	  
	 Number of Underlying Shares on the Warrant:
	  	43,478
	  

  

					
	 Tax ID No.:
	  	  

	 Address for Notice:
	  	  

		  	  

		
	 Attention:
	  	  

	 Telephone No.:
	  	  

	 Fax No.:
	  	  

	 E-mail Address:
	  	  

 

							
	Delivery Instructions, if different from above:	 		 	
				
		 		 		 	c/o                             
                    
				
		 		 		 	Street:                            
               
				
		 		 		 	City/State/Zip:                           
  
				
		 		 		 	Attention:                            
         
				
		 		 		 	Telephone
No.:                             

 

 51 

			
	NAME OF PURCHASER:	  	 MOORS AND MENDON MASTER FUND LP

 

			
	 Authorized Signatory of Purchaser

	By:	 	  

	Its:	 	  

 

					
	Aggregate Purchase Price (Subscription Amount):	  	 $999,994
	  	 
	  
 Number of Common Shares
to be Acquired:
	  	86,956
	  
	 Number of Preferred Shares to be Acquired:
	  	0
	  
	 Number of Non-Voting Preferred Shares to be Acquired:
	  	0
	  
	 Number of Underlying Shares on the Warrant:
	  	43,478
	  

  

					
	 Tax ID No.:
	  	  

	 Address for Notice:
	  	  

		  	  

		
	 Attention:
	  	  

	 Telephone No.:
	  	  

	 Fax No.:
	  	  

	 E-mail Address:
	  	  

 

							
	Delivery Instructions, if different from above:	 		 	
				
		 		 		 	c/o                             
                    
				
		 		 		 	Street:                            
               
				
		 		 		 	City/State/Zip:                           
  
				
		 		 		 	Attention:                            
         
				
		 		 		 	Telephone
No.:                             

 

 52 

			
	NAME OF PURCHASER:	  	 STIEVEN FINANCIAL INVESTORS, L.P.

 

			
	 Authorized Signatory of Purchaser

	By:	 	  

	Its:	 	  

 

					
	Aggregate Purchase Price (Subscription Amount):	  	 $4,250,009
	  	 
	  
 Number of Common Shares
to be Acquired:
	  	369,566
	  
	 Number of Preferred Shares to be Acquired:
	  	0
	  
	 Number of Non-Voting Preferred Shares to be Acquired:
	  	0
	  
	 Number of Underlying Shares on the Warrant:
	  	184,783
	  

  

					
	 Tax ID No.:
	  	  

	 Address for Notice:
	  	  

		  	  

		
	 Attention:
	  	  

	 Telephone No.:
	  	  

	 Fax No.:
	  	  

	 E-mail Address:
	  	  

 

							
	Delivery Instructions, if different from above:	 		 	
				
		 		 		 	c/o                             
                    
				
		 		 		 	Street:                            
               
				
		 		 		 	City/State/Zip:                           
  
				
		 		 		 	Attention:                            
         
				
		 		 		 	Telephone
No.:                             

 

 53 

			
	NAME OF PURCHASER:	  	 STIEVEN FINANCIAL OFFSHORE

INVESTORS,
LTD.                        

  

			
	 Authorized Signatory of Purchaser

	By:	 	  

	Its:	 	  

 

					
	Aggregate Purchase Price (Subscription Amount):	  	 $750,007
	  	 
	  
 Number of Common Shares
to be Acquired:
	  	65,218
	  
	 Number of Preferred Shares to be Acquired:
	  	0
	  
	 Number of Non-Voting Preferred Shares to be Acquired:
	  	0
	  
	 Number of Underlying Shares on the Warrant:
	  	32,609
	  

  

					
	 Tax ID No.:
	  	  

	 Address for Notice:
	  	  

		  	  

		
	 Attention:
	  	  

	 Telephone No.:
	  	  

	 Fax No.:
	  	  

	 E-mail Address:
	  	  

 

							
	Delivery Instructions, if different from above:	 		 	
				
		 		 		 	c/o                             
                    
				
		 		 		 	Street:                            
               
				
		 		 		 	City/State/Zip:                           
  
				
		 		 		 	Attention:                            
         
				
		 		 		 	Telephone
No.:                             

 

 54 

			
	NAME OF PURCHASER:	  	 GREAT OAKS STRATEGIC INVESTMENT

PARTNERS,
LP                                         
 

  

			
	 Authorized Signatory of Purchaser

	By:	 	  

	Its:	 	  

 

					
	Aggregate Purchase Price (Subscription Amount):	  	 $300,000
	  	 
	  
 Number of Common Shares
to be Acquired:
	  	26,087
	  
	 Number of Preferred Shares to be Acquired:
	  	0
	  
	 Number of Non-Voting Preferred Shares to be Acquired:
	  	0
	  
	 Number of Underlying Shares on the Warrant:
	  	6,522
	  

  

					
	 Tax ID No.:
	  	  

	 Address for Notice:
	  	  

		  	  

		
	 Attention:
	  	  

	 Telephone No.:
	  	  

	 Fax No.:
	  	  

	 E-mail Address:
	  	  

 

							
	Delivery Instructions, if different from above:	 		 	
				
		 		 		 	c/o                             
                    
				
		 		 		 	Street:                            
               
				
		 		 		 	City/State/Zip:                           
  
				
		 		 		 	Attention:                            
         
				
		 		 		 	Telephone
No.:                             

 

 55 

			
	NAME OF PURCHASER:	  	 ANDREW K. BOSZHARDT, JR.

 

			
	 Authorized Signatory of Purchaser

	By:	 	  

	Its:	 	  

 

					
	Aggregate Purchase Price (Subscription Amount):	  	 $99,997
	  	 
	  
 Number of Common Shares
to be Acquired:
	  	8,695
	  
	 Number of Preferred Shares to be Acquired:
	  	0
	  
	 Number of Non-Voting Preferred Shares to be Acquired:
	  	0
	  
	 Number of Underlying Shares on the Warrant:
	  	2,173
	  

  

					
	 Tax ID No.:
	  	  

	 Address for Notice:
	  	  

		  	  

		
	 Attention:
	  	  

	 Telephone No.:
	  	  

	 Fax No.:
	  	  

	 E-mail Address:
	  	  

 

							
	Delivery Instructions, if different from above:	 		 	
				
		 		 		 	c/o                             
                    
				
		 		 		 	Street:                            
               
				
		 		 		 	City/State/Zip:                           
  
				
		 		 		 	Attention:                            
         
				
		 		 		 	Telephone
No.:                             

 

 56 

			
	NAME OF PURCHASER:	  	 ZOLTAN ZSITVAY

 

			
	 Authorized Signatory of Purchaser

	By:	 	  

	Its:	 	  

 

					
	Aggregate Purchase Price (Subscription Amount):	  	 $100,000
	  	 
	  
 Number of Common Shares
to be Acquired:
	  	8,696
	  
	 Number of Preferred Shares to be Acquired:
	  	0
	  
	 Number of Non-Voting Preferred Shares to be Acquired:
	  	0
	  
	 Number of Underlying Shares on the Warrant:
	  	2,174
	  

  

					
	 Tax ID No.:
	  	  

	 Address for Notice:
	  	  

		  	  

		
	 Attention:
	  	  

	 Telephone No.:
	  	  

	 Fax No.:
	  	  

	 E-mail Address:
	  	  

 

							
	Delivery Instructions, if different from above:	 		 	
				
		 		 		 	c/o                             
                    
				
		 		 		 	Street:                            
               
				
		 		 		 	City/State/Zip:                           
  
				
		 		 		 	Attention:                            
         
				
		 		 		 	Telephone
No.:                             

 

 57

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00175-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00175-of-00352.parquet"}]]